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ABSTRACT 
Obesity is characterized by the accumulation of excess adipose tissue and has 
become a global health burden as the rates of obesity in both adults and children continue 
an upward trend year after year. Obesity is an important public health concern as it has 
been linked to increased prevalence of comorbidities such as type 2 diabetes, fatty liver, 
cardiovascular complications and cancer. Adipocytes are exquisitely sensitive to energy 
demands, quickly responding by releasing fatty acids, storing excess calories as 
triglycerides and/or secreting adipokines. The ability of the adipocyte to carry out its 
important functions requires perpetual remodeling of the extracellular matrix (ECM) 
surrounding the adipocyte. Metabolic dysfunction and fibrosis arise when the healthy 
balance of remodeling becomes dysregulated. The long-term goal of this project was to 
gain a deeper understanding of the events occurring within an adipocyte in the context of 
weight gain. I hypothesized that the adipocyte would play an active role in remodeling of 
the ECM. To test this hypothesis, I fed C57/Bl6 mice either high fat diet (HFD) or chow 
diet for 8, 20 and 34 weeks, at which time, the perigonadal adipose tissue was digested to 
isolate the adipocyte fraction and RNA-seq analysis was performed. My data demonstrate 
that adipocytes responded to their obesogenic, pro-inflammatory environment through 
 
 viii 
upregulation of ECM-related genes after only 8 weeks of HFD coupled with declining 
expression of mitochondrial genes and increasing genes associated with endoplasmic 
reticulum (ER) stress after 20 and 34 weeks of HFD. Overall, these data give a novel 
view into the dysfunctional state of isolated adipocytes over a time course of HFD and 
response to the changing microenvironment. 
MICAL2 is an atypical actin-modulating protein that has been shown to be 
involved in the regulation of MRTFA/SRF signaling and in cancer progression. I 
demonstrated for the first time that MICAL2 expression is enriched in the stromal 
vascular fraction of adipose tissue and is upregulated with HFD and pro-fibrotic stimulus, 
TGF-β1. I also demonstrated that MICAL2 is an anti-adipogenic and pro-fibrogenic 
protein. Altogether, the novel biology uncovered suggests a role for MICAL2 in adipose 




TABLE OF CONTENTS 
 
DEDICATION ................................................................................................................... iv 
ACKNOWLEDGMENTS .................................................................................................. v 
ABSTRACT ...................................................................................................................... vii 
TABLE OF CONTENTS ................................................................................................... ix 
LIST OF TABLES ........................................................................................................... xiv 
LIST OF FIGURES .......................................................................................................... xv 
LIST OF ABBREVIATIONS ........................................................................................ xviii 
CHAPTER ONE - INTRODUCTION................................................................................ 1 
Obesity, insulin resistance and adipose tissue remodeling ............................................. 1 
Obesity ........................................................................................................................ 1 
Insulin resistance and metabolic syndrome ................................................................ 1 
Adipose tissue and its role in metabolic homeostasis ................................................. 2 
Not all fat is equal: importance of location ................................................................. 4 
Adipocyte progenitors ................................................................................................. 6 
Adipose tissue remodeling, extracellular matrix and fibrosis ..................................... 8 
TGF-β signaling pathways ........................................................................................ 10 
Significance and research goals .................................................................................... 13 
CHAPTER TWO – MATERIALS AND METHODS ..................................................... 15 
Animal studies .............................................................................................................. 15 
 
 x 
Human adipose tissue ................................................................................................... 15 
Adipose tissue fractionation .......................................................................................... 16 
Body composition analysis ........................................................................................... 16 
Plasma collection and analysis of circulating plasma parameters ................................ 17 
Histology and staining .................................................................................................. 17 
Frozen tissue preparation .............................................................................................. 18 
Cell culture .................................................................................................................... 18 
Pathway analysis with siRNA ....................................................................................... 18 
Cell fractionation .......................................................................................................... 19 
Protein isolation and western blot analysis ................................................................... 19 
RNA and cDNA preparation ......................................................................................... 21 
Gene expression ............................................................................................................ 22 
RNAseq library preparation .......................................................................................... 22 
Gene Expression Profiling (Read Mapping, Quantification & Differential Expression)
....................................................................................................................................... 23 
Stromal vascular fraction analysis ............................................................................ 23 
Isolated adipocytes analysis ...................................................................................... 23 
Transcriptional pathway analysis of RNAseq data ....................................................... 24 
Statistical analysis ......................................................................................................... 25 
CHAPTER THREE – GENETIC AND DIET-INDUCED METABOLIC 
DYSFUNCTION LEADS TO ADIPOSE TISSUE REMODELING IN PERIGONADAL 
ADIPOSE TISSUE ........................................................................................................... 29 
 
 xi 
Introduction ................................................................................................................... 29 
Results ........................................................................................................................... 31 
Discussion ..................................................................................................................... 34 
CHAPTER FOUR – DIFFERENTIAL RESPONSE OF ADIPOSE TISSUE CELLS TO 
CHRONIC OBESOGENIC ENVIRONMENT ................................................................ 36 
Abstract ......................................................................................................................... 36 
Introduction ................................................................................................................... 36 
Obesity ...................................................................................................................... 36 
Adipose tissue remodeling and fibrosis .................................................................... 37 
Results ........................................................................................................................... 39 
Diet and aging-induced obesity leads to metabolic impairment over 34 weeks ....... 39 
Evidence of the impact of aging on circulating lipids .............................................. 41 
Obesity and adipose tissue expansion are coupled with increased liver weight and 
dysregulated adipokines. ........................................................................................... 41 
Increased adipocyte size and appearance of crown-like structures coincides with 
ectopic lipid accumulation ........................................................................................ 44 
Increased extracellular matrix in perigonadal adipose tissue with chronic high fat 
diet............................................................................................................................. 48 
Adipocytes upregulate expression of extracellular matrix genes in response to high 
fat diet. ...................................................................................................................... 50 
Isolated adipocytes display similar expression of inflammatory cytokines in 
response to high fat diet and time. ............................................................................ 52 
 
 xii 
Discussion ..................................................................................................................... 54 
CHAPTER FIVE – EVALUATION OF ADIPOCYTES TRANSCRIPTIONAL 
SIGNATURE IN RESPONSE TO HIGH FAT DIET-INDUCED REMODELING ....... 57 
Abstract ......................................................................................................................... 57 
Introduction ................................................................................................................... 58 
Results ........................................................................................................................... 60 
Adipocytes exert a dynamic transcriptional response to high fat diet stimulus. ....... 60 
Aged chow diet adipocytes cluster closer to high fat diet adipocytes. ..................... 62 
Analysis of transcriptional changes specifically in adipocytes................................. 62 
Upregulation of ECM and fibrosis-related genes and pathways in high fat diet 
adipocytes. ................................................................................................................ 65 
Downregulation in mitochondrial genes and GO terms in high fat diet adipocytes. 72 
High fat diet adipocytes have reduced OXPHOS protein. ........................................ 72 
High fat diet adipocytes have reduced lipolytic capacity ......................................... 79 
High fat diet leads to increased expression of ECM network, inflammation and ER 
stress markers in isolated adipocytes ........................................................................ 81 
Discussion ..................................................................................................................... 84 
CHAPTER SIX –THE ROLE AND REGULATION OF MICAL2 IN ADIPOGENESIS 
AND FIBROGENESIS ..................................................................................................... 87 
Abstract ......................................................................................................................... 87 
Introduction ................................................................................................................... 87 
Results ........................................................................................................................... 89 
 
 xiii 
MICAL2 is enriched in the stromal vascular fraction of human adipose tissue. ...... 89 
Mical2 is upregulated with high fat diet feeding in perigonadal adipose tissue ....... 90 
Mical2 is transiently upregulated during adipogenesis ............................................. 90 
Overexpression of mical2 suppresses adipogenesis in 10T1/2 cells ........................ 90 
Mical2 expression is transcriptionally regulated by TGF-β1 ................................... 94 
Mical2 protein expression is upregulated by TGF-β1 .............................................. 96 
Transcriptional regulation of mical2 by TGF-β does not involve RhoA or ROCK . 99 
Canonical TGF-β signaling effectors SMAD2 and SMAD3, SRF and TAZ are 
involved in the transcriptional regulation of mical2 by TGF-β1 .............................. 99 
Tdg expression is downregulated with mical2 knockdown .................................... 103 
Tdg mRNA expression is regulated by TGF-β1 and follows mical2 expression ... 103 
Discussion ................................................................................................................... 103 
CHAPTER SEVEN – FINAL CONCLUSIONS AND FUTURE DIRECTIONS ......... 109 
Summary of key findings ........................................................................................ 109 
Future directions ..................................................................................................... 117 
BIBLIOGRAPHY ........................................................................................................... 120 





LIST OF TABLES 
Table 1. siRNA constructs. ............................................................................................... 26 
Table 2. Table of antibodies.............................................................................................. 27 
Table 3. Taqman probes used for qPCR. .......................................................................... 28 
Table 4. Plasma biochemistry. .......................................................................................... 32 
Table 5. Plasma biochemistry ........................................................................................... 42 
Table 6: GO terms and associated genes upregulated in isolated adipocytes after 8, 20 and 
34 weeks of high fat diet. .......................................................................................... 68 
Table 7: GO terms and associated genes upregulated in isolated adipocytes specifically 
after 8 weeks of high fat diet..................................................................................... 69 
Table 8: GO terms and associated genes upregulated in isolated adipocytes specifically 
after 20 weeks of high fat diet................................................................................... 70 
Table 9: GO terms and associated genes upregulated in isolated adipocytes specifically 
after 34 weeks of high fat diet................................................................................... 71 
Table 10: Mitochondrial related genes and GO terms downregulated across all high fat 
diet treatment time points.......................................................................................... 74 
Table 11: Adipocyte-specific downregulated GO terms at 8 weeks................................. 75 
Table 12: Adipocyte-specific downregulated GO terms at 20 weeks............................... 76 
Table 13: Adipocyte-specific downregulated GO terms at 34 weeks............................... 77 





LIST OF FIGURES 
Figure 1: Simplified overview of canonical and non-canonical TGF-β1 signaling 
pathways. .................................................................................................................. 12 
Figure 2: Perigonadal adipose tissue has increased mRNA expression of extracellular 
matrix and inflammatory markers in both diet and genetically-induced obesity 
mouse models............................................................................................................ 33 
Figure 3: High fat diet feeding over the course of 34 weeks leads to increased bodyweight 
and metabolic impairment......................................................................................... 40 
Figure 4: Increased bodyweight is accompanied with elevated adipose and liver tissue 
weight as well as circulating markers of liver damage after 34 weeks. .................... 43 
Figure 5: Circulating plasma leptin increased with increased body weight and fat mass. 45 
Figure 6: Adiponectin content decreased in perigonadal adipose tissue after 20 and 34 
weeks of high fat diet feeding. .................................................................................. 46 
Figure 7: Increased perigonadal adipocyte size, cell infiltration and ectopic lipid 
accumulation progressing over 34 weeks. ................................................................ 47 
Figure 8: High fat diet feeding over 34 weeks leads to enhanced extracellular matrix 
staining in perigonadal adipose tissue....................................................................... 49 
Figure 9: Stromal vascular fraction cells regulation of extracellular matrix components 
gene expression is similar in response to high fat diet-induced or age-induced 
obesity. ...................................................................................................................... 51 
Figure 10: Stromal vascular cells and adipocytes have similar inflammatory cytokine 
expression in response to high fat diet-induced or age-induced obesity. ................. 53 
 
 xvi 
Figure 11: Differentially expressed genes in SVF and adipocyte fractions in response to 
high fat diet for 8, 20 or 34 weeks. ........................................................................... 61 
Figure 12: Principal component analysis of differentially expressed genes from isolated 
perigonadal adipocytes from chow diet (CD) or high fat diet (HFD) groups after 8, 
20 or 34 weeks. ......................................................................................................... 63 
Figure 13: Overview of workflow for GO term pathway analysis. .................................. 64 
Figure 14: Adipocytes upregulate extracellular matrix associated genes in response to 
high fat diet. .............................................................................................................. 66 
Figure 15: Mitochondrial related GO Terms are downregulated in adipocytes after high 
fat diet treatment. ...................................................................................................... 73 
Figure 16: Mitochondrial protein complexes are decreased over time with high fat diet 
treatment. .................................................................................................................. 78 
Figure 17: Lipolysis proteins are dramatically decreased with high fat diet (HFD) as well 
as time in CD. ........................................................................................................... 80 
Figure 18: High fat diet feeding leads to increased expression of integrins and ECM 
network markers in isolated adipocytes. ................................................................... 82 
Figure 19: High fat diet feeding leads to increased expression of ER stress and 
inflammation markers in isolated adipocytes. .......................................................... 83 
Figure 20: MICAL2 mRNA expression is enriched in the stromal vascular fraction of 
human adipose tissue. ............................................................................................... 91 
Figure 21: Mical2 mRNA expression is upregulated with high fat diet feeding in mouse 
perigonadal adipose tissue. ....................................................................................... 92 
 
 xvii 
Figure 22: Mical2 mRNA expression is transiently increased during adipogenic 
stimulation of 10T1/2 cells. ...................................................................................... 93 
Figure 23: Mical2 overexpression suppresses adipogenesis in 10T1/2 cells. ................... 95 
Figure 24: Mical2 is upregulated with TGF-β1 treatment. ............................................... 97 
Figure 25: Mical2 protein is upregulated with TGF-β1 treatment. ................................... 98 
Figure 26: The transcriptional upregulation of Mical2 expression with TGF-β1 
stimulation is not controlled by RhoA or ROCK in 10T1/2 cells........................... 100 
Figure 27: Transcriptional upregulation of Mical2 with TGF-β1 stimulation is regulated 
through SMAD2, SMAD3, SRF and TAZ expression. .......................................... 101 
Figure 28: Knockdown of Mical2 is 10T1/2 cells results in loss of Tdg expression...... 104 
Figure 29: Both basal and TGF-β1 stimulated Tdg mRNA expression are altered with 
knockdown of Mical2 expression. .......................................................................... 105 
Figure 30: Working model of Mical2 and Tdg. .............................................................. 108 
Figure 31: Working model of adipocyte in obesogenic microenvironment. .................. 113 
Figure 32: Proposed crosstalk of TGF-β stimulated ECM remodeling pathways in 





LIST OF ABBREVIATIONS 
µL ........................................................................................................................... microliter 
µm ....................................................................................................................... micrometer 
µmol ..................................................................................................................... micromole 
1/s ......................................................................................................................... per second 
Acta2 ....................................................................................... actin alpha 2, smooth muscle 
Adgre1......................................................................... adhesion G protein-coupled receptor 
Adipo...................................................................................................................... adipocyte 
Adipoq................................................................................................................. adiponectin 
α-SMA ........................................................................................ alpha smooth muscle actin 
ALT ...................................................................................................... alanine transaminase 
AMPK .............................................................................. 5′AMP-activated protein kinase 
ANOVA ................................................................................................. analysis of variance 
Apaf1........................................................................ apoptotic peptidase activating factor 1 
APC ................................................................................................adipocyte progenitor cell 
Arg1 ...................................................................................................................... arginase 1 
AST ................................................................................................... aspartate transaminase 
ATGL ........................................................................................... adipose triglyceride lipase 
ATP ................................................................................................... adenosine triphosphate 
BAT...................................................................................................... brown adipose tissue 
BCA ......................................................................................................... bicinchoninic acid 
BHBA ...................................................................................................... β-hydroxybutyrate 
 
 xix 
BMI ............................................................................................................. body mass index 
BP ..............................................................................................................biological process 
BSA .................................................................................................... bovine serum albumin 
C57/Bl6 .............................................................................................................. C57 black 6 
CC ........................................................................................................... cellular component 
Ccl2 ....................................................................................... C-C motif chemokine ligand 2 
CD .......................................................................................................................... chow diet 
CD11c ............................................................................................. integrin subunit alpha X 
CD206 ........................................................................................ mannose receptor, C type 1 
CD301 ........................................................................ C-type lectin domain containing 10A 
Cd68 ................................................................................................................ CD68 antigen 
cDNA ....................................................................... complementary deoxyribonucleic acid 
CI........................................................................................................................... complex 1 
CII ......................................................................................................................... complex 2 
CIII ........................................................................................................................ complex 3 
CIV ........................................................................................................................ complex 4 
CV ......................................................................................................................... complex 5 
CLS ...................................................................................................... crown-like structures 
Col1a1 ..................................................................................... collagen type I alpha 1 chain 
Col4a1 ...................................................................................collagen type IV alpha 1 chain 
Col6 ............................................................................................................. collagen type VI 
Col6a1 ..................................................................................collagen type VI alpha 1 chain  
 
 xx 
Col6a3 ...................................................................................collagen type VI alpha 3 chain 
Col11a2 .................................................................................collagen type XI alpha 2 chain 
Col14a1 .............................................................................. collagen type XIV alpha 1 chain 
Col16a1 .............................................................................. collagen type XVI alpha 1 chain 
Col27a1 ......................................................................... collagen type XXVII alpha 1 chain 
Col28a1 ........................................................................ collagen type XXVIII alpha 1 chain 
CST ............................................................................................. cell signaling technologies 
Ctgf ..................................................................................... connective tissue growth factor 
CypA ................................................................................................................ cyclophilin A 
DEG ........................................................................................ differentially expressed gene 
dL ............................................................................................................................. deciliter 
DMEM .............................................................................. dulbecco's modified eagle media 
DNA ................................................................................................... deoxyribonucleic acid 
DTT ................................................................................................................... dithiothreitol 
ECM ....................................................................................................... extracellular matrix 
EDTA .................................................................................. ethylenediaminetetraacetic acid 
ELISA ........................................................................ enzyme-linked immunosorbent assay 
ER ..................................................................................................... endoplasmic reticulum 
F-actin ........................................................................................................ filamentous actin 
FAT-ATTAC .................................... fat apoptosis through targeted activation of caspase 8 
FDG............................................................................. [18F]-2-fluoro-D-2-deoxy-d-glucose 
FBS ......................................................................................................... fetal bovine serum  
 
 xxi 
Fn1 ................................................................................................................... fibronectin 1  
g..................................................................................................................................... gram 
G ................................................................................................................................... gauge 
GO ................................................................................................................... gene ontology 
GSEA ....................................................................................... gene set enrichment analysis 
H&E .................................................................................................. hematoxylin and eosin 
HDL ................................................................................................ high density lipoprotein 
HFD.................................................................................................................... high fat diet 
Hif1a ..................................................................... hypoxia inducible factor 1 subunit alpha 
HRP ................................................................................................... horseradish peroxidase 
HSL ................................................................................................ hormone-sensitive lipase 
IACUC ............................................................. institutional animal care and use committee 
IBMX ............................................................................................... isobutylmethylxanthine 
IgG .......................................................................................................... immunoglobulin G 
IL-1b ..........................................................................................................interleukin 1 beta 
IL-6 ................................................................................................................... interleukin 6 
IL-10 ............................................................................................................... interleukin 10 
IL-12 .............................................................................................................. interleukin 12  
Inhba .................................................................................................. inhibin subunit beta A 
Itga3 ................................................................................................ integrin subunit alpha 3  
Itga4 ................................................................................................ integrin subunit alpha 4  
Itga5 ................................................................................................. integrin subunit alpha 5 
 
 xxii 
Itga8 ................................................................................................. integrin subunit alpha 8 
Itga9 ................................................................................................. integrin subunit alpha 9 
Itga11 ............................................................................................. integrin subunit alpha 11 
Itgax ................................................................................................ integrin subunit alpha X 
Itgb2 ................................................................................................... integrin subunit beta 2 
Itgb3 .................................................................................................. integrin subunit beta 3  
Itgb7 .................................................................................................. integrin subunit beta 7  
Itgb8 ................................................................................................... integrin subunit beta 8 
K2EDTA .......................................................... dipotassium ethylenediaminetetraacetic acid 
kg/m2 ........................................................................................... kilogram per square meter 
KHCO3 ............................................................................................... potassium bicarbonate 
L ...................................................................................................................................... liter 
LDL .................................................................................................. low density lipoprotein 
LDS ................................................................................................... lithium dodecyl sulfate 
LN2 ................................................................................................................. liquid nitrogen 
Log2FC ...............................................................................................log base 2 fold change 
LogFC ................................................................................................log base 2 fold change 
Loxl1 .......................................................................................................lysyl oxidase like 1 
LSD ............................................................................................. least significant difference 
Ly6a ....................................................................... lymphocyte antigen 6 complex, locus A 
M1 ................................................................................... classically activated macrophages 
M2 ................................................................................ alternatively activated macrophages 
 
 xxiii 
MA ................................................................................................................. Massachusetts 
MAGL ................................................................................................. monoglyceride lipase 
MCP-1 .......................................................................... monocyte chemoattractant protein 1 
mEq ................................................................................................ milliequivalents per litre 
MF ........................................................................................................... molecular function 
mg .......................................................................................................................... milligram 
mHz ........................................................................................................................ millihertz 
Mkl1 ...................................................................... myocardin related transcription factor A 
mL ............................................................................................................................milliliter 
mM ........................................................................................................................ millimolar 
mm2 ......................................................................................................... millimeter squared 
mmol .................................................................................................................... millimoles 
MMP ............................................................................................... matrix metallopeptidase 
Mmp2 ........................................................................................... matrix metallopeptidase 2 
Mmp9 ........................................................................................... matrix metallopeptidase 9 
Mmp11 ....................................................................................... matrix metallopeptidase 11 
Mmp14 ....................................................................................... matrix metallopeptidase 14 
Mrc1 ........................................................................................... mannose receptor C-type 1 
MRI .......................................................................................... magnetic resonance imaging 
mRNA ........................................................................................ messenger ribonucleic acid 
MRTFA ................................................................. myocardin related transcription factor A 
mTORC2 .................................................................................................. mTOR Complex 2 
 
 xxiv 
N ................................................................................................................................ number 
NaCl ............................................................................................................. sodium chloride 
NAFLD .............................................................................. non-alcoholic fatty liver disease 
NEFA ............................................................................................... non-esterifed fatty acid 
ng............................................................................................................................nanogram 
NH4Cl .................................................................................................... ammonium chloride 
NIK/NF-kappaB ..................................................................................................................... 
NF-κB-inducing kinase/nuclear factor kappa-light-chain-enhancer of activated B cells 
oC................................................................................................................... degrees celsius 
OXPHOS...................................................................................... oxidative phosphorylation 
padj .............................................................................................................. adjusted p-value 
PAI-1 ................................................................................ plasminogen activator inhibitor-1 
PBS .............................................................................................. phosphate buffered saline 
Pdgfra ............................................................. platelet derived growth factor receptor alpha 
PET ....................................................................................... positron emission tomography 
pg............................................................................................................................ picogram 
PGWAT ............................................................................ perigonadal white adipose tissue 
Phospho ......................................................................................................... phosphorylated 
PPAR-γ ................................................ peroxisome proliferator activated receptor gamma  
Ppia ........................................................................................... peptidylprolyl isomerase A  
PVDF ............................................................................................ polyvinylidene difluoride 
qPCR ........................................................................ quantitative polymerase chain reaction 
 
 xxv 
RhoA ................................................................................... ras homolog family member A  
RIPA ....................................................................... radioimmunoprecipitation assay buffer 
RNA ............................................................................................................. ribonucleic acid 
RNAseq ..................................................................................... ribonucleic acid sequencing 
ROCK ................................................................................................................... rho kinase 
Sca1 ........................................................................ lymphocyte antigen 6 complex, locus A 
SDS-PAGE ............................. sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sem .................................................................................................... standard error of mean 
Ser ................................................................................................................................ serine 
Serpine ......................................................................................... serpin family E member 1 
siRNA .............................................................................. small interfering ribonucleic acid 
Sm22 ...................................................................................................................... transgelin 
Smad2 ........................................................................................... SMAD family member 2 
Smad3 ........................................................................................... SMAD family member 3 
Smad4 ........................................................................................... SMAD family member 4 
Sparc ..................................................................... secreted protein acidic and cysteine rich 
SQWAT .......................................................................... subcutaneous white adipose tissue 
Srf ....................................................................................................... serum response factor 
SVF ................................................................................................ stromal vascular fraction 
T2D ................................................................................................................type 2 diabetes 
Tbp ............................................................................................ TATA-box binding protein  
TBRI ................................................................. transforming growth factor beta receptor 1 
 
 xxvi 
TBRII ................................................................ transforming growth factor beta receptor 2 
TBS-T .................................................................... tris-buffered saline with 0.2% tween-20 
TF ...................................................................................................................... thermofisher 
Tgfb1 ............................................................................ transforming growth factor beta one 
Tgfbr1 ............................................................... transforming growth factor beta receptor 1 
Tgfbr2 ............................................................... transforming growth factor beta receptor 2 
Timp1 ............................................................................. TIMP metallopeptidase inhibitor 1 
Tnc ........................................................................................................................ tenascin C 
Tnfa ................................................................................................... tumor necrosis factor a 
TNF-α................................................................................................ tumor necrosis factor a 
U ..................................................................................................................................... units 
UCP-1 .................................................................................................. uncoupling protein 1 
V ..................................................................................................................................... volts 
Vegf............................................................................ vascular endothelial growth factor A  
w .................................................................................................................................... week 
WB ..................................................................................................................... western blot 
wk .................................................................................................................................. week 
x..................................................................................................................................... times 





CHAPTER ONE - INTRODUCTION 
 
Obesity, insulin resistance and adipose tissue remodeling 
Obesity 
Obesity is characterized by the accumulation of excess adipose tissue and has 
become a global health burden as the rates of obesity in both adults and children continue 
an upward trend year after year 1-3. Body mass index (BMI) is a widely accepted 
measurement used for determining where on the weight spectrum (from underweight to 
obese) an individual falls based on a calculation that takes into account a person’s weight 
and height. Based on this measurement, a person is determined to be obese when their 
BMI is >30 kg/m2 4. The rise in obesity is an important public health concern as elevated 
BMIs of >30 kg/m2 are linked to increased all-cause mortality at earlier ages as well as 
increased prevalence of comorbidities such as type 2 diabetes, non-alcoholic fatty liver 
disease (NAFLD), cardiovascular complications and cancer 5-7.   
Insulin resistance and metabolic syndrome 
 
Insulin resistance is defined as a condition in which higher levels of insulin are 
required to achieve the same regulation of blood glucose levels compared to an insulin 
sensitive person 8,9. Importantly, insulin resistance is considered to be a stepping stone 
between obesity and development of metabolic syndrome. Metabolic syndrome is an 
umbrella term to describe a collection of conditions (dyslipidemia, elevated blood 




type 2 diabetes, fatty liver and cardiovascular disease 10,11. Insulin acts on adipocytes by 
stimulating glucose uptake, triglyceride synthesis and suppressing lipolysis, which 
indirectly results in stopping the production of glucose from the liver 12,13. Adipose tissue 
insulin resistance is characterized by the inability of insulin to suppress lipolysis, leading 
to the release of non-esterified free fatty acids (NEFAs) and glycerol into the circulation 
under fed conditions 14. Interestingly, large adipocytes have been linked to increased rates 
of lipolysis compared to smaller adipocytes isolated from the same person 15. Elevated 
circulating NEFAs have been shown to be associated with impaired insulin signaling in 
muscle and liver as well as inappropriate ectopic storage of NEFAs in non-adipose tissue 
such as liver, skeletal muscle and heart all contributing to metabolic complications 14. A 
hallmark of type 2 diabetes is decreased insulin sensitivity, leading to increased 
circulating insulin compared to healthy individuals 16.  
The mechanism by which obesity leads to insulin resistance in adipose tissue and 
the role of inflammation in the process has been a topic of debate. A recent study using a 
mouse model of genetically-induced insulin resistance concluded that insulin resistance 
in fact precedes inflammation in adipose tissue 17. Shimobayashi and colleagues 
demonstrated that insulin signaling through mTORC2 in adipocytes suppresses the 
expression of inflammatory cytokine, MCP-1, and thus keeps inflammation and 
recruitment of M1 pro-inflammatory macrophages down in healthy tissue 17. 
Adipose tissue and its role in metabolic homeostasis 
The adipose tissue was once thought of as an inert energy sink and a cosmetic 




the various functions and importance of adipose tissue in maintaining whole body 
homeostasis 18. A central role of adipose tissue is the safe storage of excess nutrition as 
triglycerides that make up the lipid droplet in an adipocyte as well as the hydrolysis of 
these triglycerides to release NEFAs into the circulation for use by other tissues during 
fasting or exercise 19. In addition to this, adipose tissue is an endocrine organ secreting an 
array of bioactive proteins referred to adipokines. Adipokines are secreted proteins that 
are produced by adipocytes 20. These secreted proteins communicate nutritional status 
throughout the body, influencing both glucose and lipid metabolism 21.  
Adiponectin and leptin are two adipokines that play an important role in 
regulating metabolic homeostasis. Leptin was first discovered at the end of the 20th 
century and was paramount in suggesting that the adipose tissue was much more than 
simply a place for calorie storage 22. Leptin is released from the adipocyte in response to 
feeding to regulate the appetite and increase energy expenditure through its action in the 
brain 23. The actions of leptin are clearly demonstrated by 2 mouse models of defective 
leptin production or absence of the leptin receptor, ob/ob and db/db mice respectively 24. 
Both mice have insatiable appetites and become obese very quickly on standard chow 
diet highlighting the action of leptin. Adiponectin has insulin-sensitizing properties and 
stimulates lipid oxidation and glucose uptake through the activation of AMPK 25. In 
obesity, circulating levels of adiponectin are greatly reduced in contrast to leptin 26. 
Furthermore, circulating adiponectin level is negatively correlated with adipocyte size in 





Adipose tissue is made up predominantly of adipocytes, which are responsible for 
the storage of excess calories in the form of triglycerides as well as release of NEFAs 
during times of energy demand. Cells present in the stromal vascular compartment of the 
adipose tissue include endothelial cells, immune cells, fibroblasts and preadipocytes 28. 
Adipocytes are a post-mitotic cell and have a lifespan of approximately 10 years in 
humans with an average yearly turnover rate of 10% 29. Interestingly, the number of 
adipocytes that a person has remains relatively constant throughout adult life even during 
weight gain and loss 29,30. 
Lipodystrophy is defined as having very little adipose tissue 31. Interestingly, this 
phenotype recapitulates features of metabolic syndrome, namely insulin resistance, 
diabetes, fatty liver and dyslipidemia as seen in obesity. This is due to there not being 
enough healthy adipose tissue to safely store excess nutrition leading to lipotoxicity 
(ectopic storage of lipids in other organs) as well as a decrease in circulating adipokines 
32,33. Thus highlighting the importance of the quantity and health of adipose tissue in the 
regulation of whole body metabolic homeostasis. 
Not all fat is equal: importance of location 
Unlike other organs, the adipose tissue occurs throughout the body in different 
regions or depots 34. In humans, adipose depots can be broadly segregated into 3 groups: 
intra-abdominal (visceral), upper-body/abdominal subcutaneous and lower body 
subcutaneous 35. Visceral adipose tissue, present in the intra-abdominal space, surrounds 
our organs providing mechanical protection. Due to the invasiveness of accessing visceral 




accessibility compared to other visceral depots. While rodents do not have an omental 
depot per say, the depot that is considered the most analogous, although not a perfect 
match, to the human omental depot is the perigonadal depot 36. Subcutaneous adipose 
tissue is mainly located just beneath the skin in the abdominal, buttocks and thigh regions 
35. The primary subcutaneous depot in humans is the gluteal-femoral depot whereas in 
rodents it is the inguinal depot 35. Intriguingly, new fat pads are still being identified in 
rodents and correlated to those in human which will allow for more precise study and 
translation in the future 37.  
Increased visceral adiposity has been shown to have negative metabolic 
consequences in part to increased inflammatory adipokine secretion and decreased insulin 
sensitivity compared to increased subcutaneous fat 26,38. In contrast, increased lower body 
subcutaneous adipose tissue mass in the gluteal-femoral region has been correlated with 
better insulin sensitivity 39,40.  
In addition to adipose tissue residing in different depots throughout the body, 
adipose tissue has also been divided into different color categories according to function. 
In general, adipose tissue can be classified as white, brown, beige or pink. White adipose 
tissue is the most abundant and serves as a storage facility with a large unilocular lipid 
droplet. Brown adipose tissue (BAT), named after its color due to high mitochondria 
content, primarily generates heat through the uncoupled oxidation of nutrients by 
uncoupling protein-1 (UCP-1), a BAT-specific protein located within the mitochondrion 
41. Brown adipocytes are also visually distinct from white adipocytes in that they have 




the interscapular region 36. Until relatively recently, adult humans were thought to be 
void of brown fat after infancy. However patients undergoing [18F]-2-fluoro-D-2-deoxy-
d-glucose (FDG) positron emission tomography (PET) tracer studies for cancer diagnosis 
demonstrated elevated uptake of the tracer in the supraclavicular and spinal regions 
leading researchers to question what metabolically active tissue was present. Further 
investigation by biopsy revealed in both cancer patients as well as cold-challenged 
healthy adults proved that these regions in fact contained UCP-1 expressing brown 
adipocytes 43,44. Beige adipocytes reside in white adipose tissue and are somewhere in 
between a white and brown adipocyte as they express genes present in both white and 
brown adipocytes as well as a distinct set of their own 45,46. They have low levels of 
thermogenic activity and are considered to be inducible adipocytes. Currently, the origin 
of beige adipocytes whether from a specific precursor or from trans-differentiation of a 
white adipocyte is still unknown 45. Pink adipocytes are present in the mammary tissue 
and play a role in lactation 47,48. Given the energy-wasting characteristic of brown and 
beige adipocytes, browning or beiging of white adipose tissue has been proposed as a 
mechanism to fight obesity through the ‘wasting’ of excess energy and is an area of 
active research. For the purposes of this thesis, I will focus on white adipose tissue. 
Adipocyte progenitors 
Adipose tissue expansion occurs either through hypertrophy (increase size of 
existing adipocytes) or through hyperplasia (formation of new adipocytes through 
adipogenesis) 49. Intriguingly, the primary method of expansion differs depending on the 




expands through hyperplasia as well as hypertrophy. In contrast, subcutaneous adipose 
expands primarily through hypertrophy 50,51. The method of expansion is important in the 
context of obesity as there is ample evidence linking large, hypertrophied adipocytes with 
increased circulating NEFA and insulin and increased prevalence to develop insulin 
resistance and type 2 diabetes 15,52. Whereas in people with similar BMI that have smaller 
adipocytes in their adipose depots, remain more glucose tolerant and are metabolically 
healthier despite having excess adipose tissue 15. Multiple studies provide compelling 
data that the presence of smaller adipocytes results in healthier adipose tissue and thus 
that adipogenesis is a preferred method of expansion from the view point of metabolic 
homeostasis 53,54.  
Considerable effort has been put into understanding the origins of adipocyte 
progenitors (APC) with many mouse models being generated for lineage-tracing 
experiments to identify the adipocyte precursor cell, these studies were recently reviewed 
55. It is unlikely that there is one single adipocyte precursor cell as a recent study 
suggested that adipocytes in subcutaneous and visceral adipose depots arise from distinct 
lineages 56. While another group of researchers suggested that adipocytes within the same 
depot arise from different lineages 55. Unsurprisingly, there is currently no consensus on a 
set of cell surface markers defining an APC however PDGFR-α has been accepted as 
being one of the markers of a progenitor cell to a white adipocyte 57.  
The process of precursor cell origin, fate determination and adipogenesis is 
further complicated and adipocyte plasticity further stretched with the findings that 




cells in tumour growth 58,59, wound healing60,61 and lactation62. These data also call into 
question our understanding of adipocytes being a terminally differentiated cell. In the 
context of dermal wound healing, mice that genetically lack the capacity to develop 
adipose tissue or wild type mice treated with a PPAR-γ antagonist to block adipogenesis 
are severely deficient in their abilities to heal dermal wounds thus providing support of 
the important role that adipocytes play in this process 63. 
Adipose tissue remodeling, extracellular matrix and fibrosis 
Adipocytes are exquisitely sensitive to energy demands quickly responding 
through either the release of fatty acids, storage of excess calories as triglycerides and/or 
secretion of adipokines. The dynamic ability of the adipocyte to regulate its size through 
quick expansion or shrinkage requires continual remodeling of its environment, including 
the extracellular matrix (ECM) 64-67. The ECM is an important component of adipose 
tissue as it provides adipocytes with structural support and protection from mechanical 
stresses. 
Remodeling in healthy adipose tissue involves the continuous turnover of ECM 
proteins such as collagen, fibronectin, proteoglycans and various others by a perpetual 
cycle of matrix deposition by adipocytes and other SVF cells and degradation by 
enzymes such as metalloproteases (MMPs) 68.  This continuous turnover of ECM is 
necessary to maintain the function of the tissue through the unrestricted expansion and 
contraction of adipocytes 64,65. In addition to ECM turnover, angiogenesis within the fat 
pad keeps pace with the expansion rate during healthy remodeling, ensuring that the 




when the healthy balance of remodeling becomes dysregulated. Increased deposition of 
ECM and decreased degradation or turnover occurs, combined with an increase in 
crosslinking of ECM fibers ultimately leading to adipocyte dysfunction and fibrosis 70,71. 
Insulin, which is frequently elevated during metabolic dysfunction, has also been shown 
to be a regulator of the extracellular matrix (ECM) in muscle and liver 72,73. 
Macrophages which reside in the stromal vascular fraction play a role in 
angiogenesis through the secretion of MMPs and stimulation of VEGF 74. It is well 
understood that as obesity develops and the adipose tissue continues to expand, the 
density of macrophages into adipose tissue increases 75,76. At the simplest interpretation, 
macrophages can be divided into 2 classes, M1 and M2, based on their inflammatory 
profile. Classically activated macrophages, M1, are the body’s first line responders to 
pathogens and are considered pro-inflammatory. M1 macrophages are identified through 
the expression of CD11c, CCR2 and release of pro-inflammatory cytokines TNF-α, IL-6 
and IL-12 77. M2 macrophages are alternatively activated and are involved in tissue 
remodeling and wound healing 78. M2 macrophages differ from M1 macrophages through 
the expression of CD206, CD301 and through the secretion of IL-10, arginase-1 and 
MMPs. Ablation of adipocytes using a mouse model of targeted caspase-8 activation and 
activation of apoptosis in adipocytes (FAT-ATTAC) demonstrated that adipocyte death 
and the subsequent massive reduction of adipose fat pads (remodeling), that the 
predominant population of macrophages were M2 and not M1 79. This was surprising 
because it was previously thought that in obese adipose tissue, dying or dead adipocytes 




and that M2 macrophages were more populous in lean adipose tissue 80. Macrophages 
play an important role in adipose tissue remodeling through the clearance of debris from 
dead adipocytes and in sequestering the newly naked lipid droplet from the dead 
adipocyte 81,82. 
The composition of the ECM shapes the behavior of neighboring cells as isolated 
preadipocytes have been shown to express a gene signature that is unique to the depot of 
their origin 83. Interestingly, when cultured in-vitro on ECM produced by preadipocytes 
from a different depot, a given preadipocyte differentiation mimics that of the 
preadipocytes that produced the ECM, rather than those of their depot of origin 84. This 
has also been recently demonstrated in vivo when preadipocytes isolated from 
subcutaneous or visceral depots behaved as expected in the injection site not as from their 
tissue of origin 85. These findings highlight the importance of thoroughly understanding 
the changes in the extracellular matrix composition during obesity-driven remodeling. 
TGF-β signaling pathways 
It has been well documented that the expression of multiple cytokines, such as 
transforming growth factor beta 1 (TGF-β1), are increased in obese adipose tissue 86-88. 
TGF-β1 is a pleiotropic cytokine involved in many processes such as cell migration and 
differentiation, cell cycle arrest, inflammation, as well as anti-inflammatory responses 89. 
Interestingly, preadipocytes proliferate with TGF-β1 stimulation; however TGF-β1 has 
also been shown to be anti-adipogenic 90-93. TGF-β1 is part of a larger family of cytokines 
and growth factors referred to as the TGF-β superfamily and is dependent on the ECM 




production of collagen 95. TGF-β1 typically exists embedded in the ECM in an inactive 
state, bound to its latent TGF-β-binding protein 94,96. In order to become active, TGF-β1 
must be cleaved from its latent protein through the action of matrix metalloproteases 
(MMPs) and plasmins within the ECM, highlighting the interplay of TGF-β1 signaling 
and regulation of ECM remodeling 97. Once TGF-β1 has been released from the latent 
complex it binds to its receptor TβRII which initiates its heterodimerization with a second 
receptor, TβRI. The dimerization of these receptors initiates the intracellular signaling of 
TGF-β1 through either canonical or non-canonical pathways 98. The canonical signaling 
pathway of TGF-β1 is through SMAD2 and SMAD3 activation through phosphorylation 
by TβRI (Figure 1). Once activated, SMAD2 and SMAD3 bind to co-SMAD, SMAD4, 
and in complex translocation into the nucleus and where SMAD2 and SMAD3 bind to 
SMAD-binding elements (SBE) along with cofactors to initiate transcription of target 
genes such as CTGF, COL1A1 and PAI-1 99. TGF-β1 also signals through non-canonical 
pathways such as the RhoA/ROCK/MRTFA pathway 100 (Figure 1). Activation of 
Rho/ROCK leads to the formation of stress fibers resulting in the translocation and 
activation of a transcriptional cofactor, myocardin-related transcription factor A 
(MRTFA) 101,102. MRTFA binds to cofactors to initiate transcription of its target genes 
such as ACTA2, ITGA5, SM22 and other fibrogenic genes 103 MRTFA was also recently 
shown to act as a determinant of cell fate and drive a pro-fibrotic phenotype in 





Figure 1: Simplified overview of canonical and non-canonical TGF-β1 signaling 
pathways. 
To activate intracellular signaling pathways, TGFβ-1 binds to its receptor, TβRII, 
leading to its heterodimerization with another receptor TβRI 98.  In canonical 
signaling, transcriptional activators, SMAD2 and SMAD3, are phosphorylated by the 
activated TβRII/TβRI complex. Phosphorylation of SMAD2 and SMAD3 activates 
them to bind to their co-SMAD, SMAD4. These SMAD complexes then translocate 
into the nucleus where SMAD2 and SMAD3 bind to SMAD binding elements and 
initiate transcription of their target genes 99. In non-canonical TGFβ-1 signaling such 
as through the stimulation of RhoA, a different set of transcriptional activators SRF 
and MRTFA are set into motion through the modulation of the actin cytoskeleton by 
RhoA/ROCK activity 100. MRTFA, which is sequestered by g-actin in the cytoplasm 
under basal conditions, is released to translocate into the nucleus upon initiation of 
RhoA/ROCK signaling cascade 101,102. Once in the nucleus, MRTFA forms a complex 






Significance and research goals 
Obesity in adults continues to rise in the developed world partly due to increased 
caloric intake and decreased energy expenditure 1. During times of overnutrition or 
caloric excess, the well-known role of adipose tissue is to store the excess calories 
through either expansion of lipid droplets, a process known as hypertrophy, or by 
increasing adipocyte number, a process referred to as hyperplasia 105. During times of 
adipose tissue growth, the adipose tissue undergoes remodeling 28. The extracellular 
matrix (ECM) provides adipocytes within adipose tissue structural strength and 
mechanical protection from external forces 66. Metabolic dysfunction, which precedes 
comorbidities such as type 2 diabetes and cardiovascular complications, has been shown 
to arise when remodeling becomes dysregulated, leading to adipocyte dysfunction and 
fibrosis 70,71. The long-term goal of this research is to gain a deeper understanding of the 
kinetics of adipose tissue remodeling in the context of weight gain, to help identify 
potential targets for therapeutics against obesity-related metabolic diseases. My 
hypothesis is that the adipocyte will play an independent role from the SVF in 
remodeling during HFD-driven weight gain. 
In order to test my hypothesis, I fed C57/Bl6 mice either high fat diet or chow 
control diet for 8, 20 and 34 weeks starting at 6 weeks of age. At the end of each study, 
the perigonadal fat pads were excised and digested to separate the stromal vascular 
fraction (SVF) from the adipocyte fraction. I chose to focus on the perigonadal adipose 
depot given this depot’s capacity to remodel initially through a combination of 




85, demonstrating its capacity to remodel. I then examined each fraction by RNA-seq to 
compare the transcriptional landscape of each cell fraction and the changes incurred due 
to high fat diet (HFD) or age-related obesity. 
Considerable effort has been made for understanding the dynamic response of the 
cells within the stromal vascular fraction or total adipose tissue to an obesogenic 
microenvironment 80,104. However, few studies have specifically examined the isolated 
adipocyte 106,107 let alone over a time course. This thesis project provides a novel look at 
the transcriptional changes in isolated adipocytes in response to high fat diet-induced 
remodeling after 8, 20 and 34 weeks. My data demonstrate that adipocytes respond to a 
chronic HFD through the upregulation of extracellular matrix-related genes after only 8 
weeks coupled with declining mitochondrial genes, OXPHOS proteins and increasing 
endoplasmic reticulum (ER) stress transcriptional pathways after 20 and 34 weeks of high 






CHAPTER TWO – MATERIALS AND METHODS 
Animal studies 
 B6.Cg-Lepob/J (hereon referred to as ob/ob) male mice were purchased from 
Jackson Laboratories (stock number 000632) and were maintained on a standard chow 
diet. C57BL/6J male mice were purchased from Jackson Laboratories (stock number 
000664) and fed either a high fat diet (HFD) containing 60% kcal from fat (D12492; 
Research Diets) or control chow diet (D12450B or D12450K; Research Diets) starting 
from 6 weeks of age for 8, 20 or 34 weeks. Mice were maintained on a standard 12hr 
light/dark cycle with ad libitum access to food and water. Bodyweights were measured 
prior to study and at the end of the study under fed conditions. On the final day of each 
study time point, mice were fasted either for 6 hours (4:00 – 10:00) or overnight (18:00 – 
10:00) by the removal of food but with free access to water. Mice were euthanized using 
carbon dioxide asphyxiation followed by cervical dislocation. All harvested tissues were 
wrapped in foil and immediately snap-frozen in liquid nitrogen (LN2). At the completion 
of the study, tissues were stored at -80oC. 
All experimental protocols performed on animals were in accordance with 
regulations and established guidelines and were reviewed and approved by Institutional 
Animal Care and Use Committee (IACUC) at Pfizer Inc, Cambridge, MA. 
Human adipose tissue 
Human adipose tissue samples were procured from Tufts University (Medford, MA) from 
patients undergoing bariatric or hernia surgery. All patients gave written and informed 




established guidelines that were reviewed and approved by Institutional Review Board 
for Protection of Human Subjects in Research (IRB) at Tufts University. 
Adipose tissue fractionation 
 Dissociation media was prepared by adding 2 grams of bovine serum albumin 
(BSA) to 100 mL of 4.5g/L glucose DMEM media (Invitrogen) and warmed in a 37oC 
water bath to dissolve. Adipose tissue was dissected at the termination of the study. The 
fat pad was rinsed with PBS before being gently minced in dissociation media with 
scissors and a razor blade. The minced tissue was then digested by transferring the 
minced tissue to a 50 mL falcon tube containing 25 mL of 1 mg/mL type I collagenase 
(Worthington) dissolved in dissociation media and placed in a 37oC water bath with 
gentle shaking for approximately 40 minutes. The dispersed tissue was then passed 
through a 100 µm mesh filter and centrifuged at 200xg for 5 minutes. The floating 
adipocytes were carefully removed and added to a tube containing approximately 5 
volumes of trizol (Qiagen) and immediately snap frozen in a bath of LN2. The pelleted 
SVF was resuspended in erythrocyte lysing buffer (155 mM NH4Cl, 10 mM KHCO3, 1 
mM EDTA), incubated at room temperature for 3 minutes and then centrifuged at 200xg 
for 5 minutes. Pelleted SVF was resuspended in 2 mL trizol (Qiagen) and immediately 
snap frozen in a bath of LN2. Cell fractions were stored at -80oC. 
Body composition analysis 
 After 34 weeks of HFD, the relative total body fat mass and lean mass of mice 




Plasma collection and analysis of circulating plasma parameters  
Whole blood was collected by cardiac puncture using a 26G needle immediately 
following euthanasia by carbon dioxide and cervical dislocation. Whole blood was added 
to K2EDTA-containing collection tubes, gently inverted to mix and stored on ice before 
being centrifuged at 13,800xg for 10 minutes at 4oC. Plasma was carefully removed and 
transferred to clean, pre-chilled microcentrifuge tubes on ice and analyzed immediately 
or stored at -80oC for analysis at a later time. Glucose, ALT, AST, cholesterol, NEFA, 
glycerol, triglycerides and lactate were measured using a Siemens Advia 1800 Chemistry 
Analyzer (Siemens). Insulin was measured using Stellux Chemi Rodent Insulin ELISA 
kits (Alpco). Leptin was measured using Luminex magnetic bead assay kit 
(Thermofisher). 
Histology and staining 
 Adipose and liver tissues were processed with a standard paraffin-embedding 
protocol after fixation in 10% neutral-buffered formalin (Fisher Scientific), cut into 5 µm 
sections and mounted onto slides (Charles River). H&E staining was done by Charles 
River laboratories using their in-house protocols. Elastin staining was performed using an 
Elastica van Gieson staining kit (Millipore) according to manufacturer instructions. 
Picrosirius red staining was performed as previously described 108,109. Bright field images 





Frozen tissue preparation 
 Frozen adipose tissue was powdered by gently hammering in foil on a pedestal 
partially submerged in LN2. Frozen pieces of tissue were hammered until pulverized to a 
fine, uniform powder. Powdered tissue was then transferred to a vial, pre-chilled in LN2. 
Powdered tissues were then returned to -80oC for storage or prepared for further analysis.  
Cell culture 
 C3H 10T1/2 cells (ATCC) were maintained in growth media (high glucose 
DMEM with 10% fetal bovine serum (FBS)) in a 37oC/5% CO2 incubator. Care was 
taken to split the cells when they reached ~70% confluency in culture flasks. For 
differentiation to adipocytes, cells were plated and grown to confluence (typically took 3 
days) before treatment with adipogenic cocktail for 48 hours (high glucose DMEM + 
10% FBS + 5 µM dexamethasone, 0.5 mM isobutylmethylxanthine (IBMX), 860 nM 
human insulin, 125 µM indomethacin. After 48 hours, cell media was changed to 
maintenance media (high glucose DMEM + 10% FBS + 860 nM human insulin). Cells 
were grown in maintenance media for 5 days, carefully changing the media every other 
day. High glucose DMEM, FBS and human insulin were purchased from Thermofisher. 
Dexamethasone, IBMX and indomethacin were purchased from Sigma. 
Pathway analysis with siRNA 
 siRNA was solubilized according to manufacturer instructions (Thermofisher). 
siRNA complexes for transfection were prepared using Viromer Blue (Lipocalyx, 
Germany) according to manufacturer protocol for reverse transfections. Final 




assay plates with siRNA complexes at a subconfluent density and incubated overnight at 
37oC/5% CO2. After 24 hours recovery period, the media was removed, cells rinsed with 
warm PBS and serum starvation media (high glucose DMEM + 0.5% BSA) added to 
appropriate wells. Cells were serum-starved in a 37oC/5% CO2 incubator for 16 hours. 
After the serum starvation period, media was removed and fresh serum-starvation media 
containing either vehicle or 1 ng/mL rhTGF-β1 (R&D systems) was added to the 
appropriate wells. For 6 well plates, 2.5 mL and for 24 well plates, 750 µL treatment 
volumes were used. Cells received rhTGF-β1 stimulation for 8 hours prior to being 
harvested for RNA or protein.   
Cell fractionation 
10T1/2 cells were plated into 100 mm dishes at a subconfluent seeding density in growth 
media. After treatment, cell fractionation of 10T1/2 cells was performed using 
Subcellular Protein Fractionation Kit for Cultured Cells according to manufacturer 
instructions (Thermo Scientific). Fractions were analyzed by western blot. 
Protein isolation and western blot analysis 
 Total adipose tissue lysates were made by scooping approximately 200 mg 
powdered adipose tissue (prepared as described above) into a microcentrifuge tube on ice 
containing 400 µL RIPA buffer (ThermoFisher) supplemented with 1% triton X-100 
(Sigma) and 1x protease and phosphatase inhibitor cocktail (Cell Signaling 
Technologies). After vortexing to ensure thorough mixing, samples were sonicated for 2 
rounds of 3 seconds at 30 mHz with a brief pause in between rounds. Careful attention 




samples were cleared by centrifugation at 18,800xg for 15 minutes at 4oC. The 
supernatant was careful removed, avoiding the lipid cake at the surface as well as 
particulates at the bottom of the tube. The supernatant was transferred to a clean, pre-
chilled microcentrifuge tube and cleared again as described above. After clearing, protein 
concentrations were determined by BCA assay (Pierce). For western blot analysis, equal 
amounts of protein from cleared tissue lysates were prepared with 4x Nupage LDS 
loading buffer (ThermoFisher) and 1x reducing agent (DTT; ThermoFisher) before being 
heated for 10 minutes at 70oC. After a brief cooling period until no longer warm to the 
touch, the samples were loaded into 26 lane 4-20% Tris-Glycine midi gels (Biorad) and 
separated by SDS-PAGE according to manufacturer instructions (Biorad). After SDS-
PAGE was complete, the proteins were then transferred to a pre-activated and transfer 
buffer equilibrated polyvinylidene difluoride (PVDF) membrane (Biorad) by wet tank 
transfer. The wet transfer conditions were 90 minutes at 85V keeping the transfer 
chamber cold with an internal ice pack and surrounding the chamber with ice. Transfer 
buffer was 1x Tris/Glycine transfer buffer (Biorad) supplemented with 20% methanol 
(Fisher). Following transfer, PVDF membranes were blocked with 5% non-fat milk 
(Biorad) in tris-buffered saline supplemented with 0.2% tween-20 (TBS-T; 50 mM Tris-
Cl, pH 7.5, 150 mM NaCl, 0.2% tween-20) for 1 hour at room temperature with gentle 
rocking. Membranes were then rinsed with TBS-T before being incubated overnight at 
4oC with gentle rocking with primary antibodies prepared in 5% BSA/TBS-T with 
dilutions specified in Table 2. The following day, primary antibodies were removed and 




were incubated with appropriate HRP-linked secondary antibodies diluted in 5% non-fat 
milk in TBS-T for 1 hour at room temperature with gentle rocking. Membranes were then 
washed 3x 5 minutes with TBS-T buffer. Proteins were detected using SuperSignal™ 
West Femto Maximum Sensitivity Substrate kit (ThermoFisher). Membranes were 
exposed and images were captured using a ChemiDoc XRS+ system (Biorad) with 
careful monitoring of exposure time to avoid saturation of signal. All antibodies and 
dilutions used are listed in Table 2. Densitometry analysis was done using Image Lab 
5.2.1 software (BioRad). 
RNA and cDNA preparation 
 Isolated adipocytes and stromal vascular cells snap frozen in trizol were thawed 
on ice and then transferred to Fastprep matrix D lysing tubes (Mp Biomedicals) for 
homogenization using a Qialyzer instrument (Qiagen). Cells were homogenized with 2 
cycles of 2 minutes at 20 1/s frequency, rotating tubes within holders (outside to inside 
and vice-versa) between rounds. RNA was extracted from the tissue homogenates using 
the RNeasy Lipid Tissue Mini kit and the Qiagen user-developed protocol titled 
Purification of total RNA from fatty tissues using the RNeasy® Lipid Tissue Mini Kit 
and MaXtract High Density (Qiagen). On-column DNA digest was performed for all 
samples according to manufacturer protocol (Qiagen). RNA was quantified using a 
Nanodrop 8000 spectrophotometer and quality was assessed using an Agilent 4100 
Bioanalyzer (Agilent). cDNA was synthesized from RNA using High-capacity cDNA 




 For 10T1/2 cells, at the end of the experiment, cells were washed with PBS and 
then lysed with RLT buffer containing 1x beta-mercaptoethanol (Thermofisher) and then 
either stored at -80oC until ready to process or RNA was extracted immediately using 
RNeasy midi kit (Qiagen) with on-column DNA digest according to manufacturer 
protocol (Qiagen). RNA was quantified using a Nanodrop 8000 spectrophotometer and 
quality was assessed using an Agilent 4100 Bioanalyzer (Agilent).. cDNA was 
synthesized from RNA using High-capacity cDNA reverse transcription kits (Applied 
Biosystems). 
Gene expression 
 Real-time quantitative PCR (qPCR) was performed using a Quantstudio 7 flex 
instrument (Applied Biosystems) using Taqman Fast advanced mastermix (Applied 
Biosystems) and appropriate taqman probe for the target. Relative expression was 
normalized to housekeeping genes (Ppia and Tbp). All taqman probes were purchased 
from ThermoFisher and are listed in Table 3. 
RNAseq library preparation 
 cDNA libraries for RNA-seq analysis were prepared from total RNA (isolated as 
described above) according to Illumina TruSeq stranded mRNA sample prep LS protocol. 
Pooled sample libraries were sequenced on Nextseq 500 instrument with Nextseq 




Gene Expression Profiling (Read Mapping, Quantification & Differential Expression) 
Stromal vascular fraction analysis 
This method was written by Joseph Orofino (Perissi Lab, Boston University). He 
performed the differentially expressed gene analysis of the SVF data. 
Raw sequencing reads were subjected to quality control analysis via FastQC110 
and reports aggregated via MultiQC111 . Reads were then trimmed based on a sliding 
window and presence of adapter sequences using Trimmomatic112 set to the following 
parameters: ILLUMINACLIP::2:30:10 LEADING:3 TRAILING:3 
SLIDINGWINDOW:4:15 MINLEN:50. Salmon113 was used to quantify the expression of 
transcripts to a reference transcriptome containing protein coding and long non-coding 
RNAs from the gencode M10 annotation before aggregation to the gene level. Only genes 
with a raw count of greater than 5 and present in at least half of the replicates were used 
for downstream analysis. Normalization and differential expression were performed using 
DESeq2114 set to default parameters. 
Isolated adipocytes analysis  
This method was written by Dr. Ramya Gamini (Pfizer, Cambridge, MA.). She 
performed the differentially expressed gene analysis of the isolated adipocyte RNA-seq 
data. 
The raw RNA-seq fastq files were processed using the count-based differential 
expression analysis best practice protocol115 to quantify for gene expression. 




STAR aligner116. featureCounts was used to count the number of reads unambiguously 
overlapping each gene, where each gene was considered to be the union of its exons117 
with GENCODE annotation (vM2 for mouse). Sample normalization factors were 
computed using the EdgeR TMM method 118. Unless otherwise stated, all counts per 
million (CPM) and log2CPM values are computed using these normalization factors. We 
converted the gene symbols to Entrez IDs using the annotations in the mygene.info 
package 119. Of the 38924 genes, 9690 gene symbols did not have an associated Entrez ID 
and were discarded from this study. Only genes with gene-expression data above 
log2CPM of 2.0 were considered expressed, filtering the rest, resulting in a gene list of 
11600 informative genes. The resulting genes with Entrez IDs correspond to the set of 
‘background or detected genes’ consisting of 11600 genes. The biological replicates for 
each condition were pooled for differential expression analysis.  Genes with a q-value of 
< 0.05 were considered significantly differentially expressed. 
Transcriptional pathway analysis of RNAseq data 
 Differentially expressed genes were selected based on padj <0.05. GSEA pathway 
enrichment analysis was conducted on differentially expressed gene lists that were ranked 
by logFC 120,121. Lists of differentially expressed genes were also analyzed for enriched 
GO terms122,123 using the online EnrichR tool 124,125 and Revigo 126. Differentially 
regulated genes associated with mitochondria were identified by comparing gene lists to 





 Data were analyzed using Graphpad Prism 7 software (Graphpad) and are 
presented as mean ± standard error of mean (SEM). Group comparisons were analyzed 
using either two-tailed unpaired student t test or a two-way ANOVA followed by 
multiple comparisons correction method stated in figure legend. Differences were 











Table 2. Table of antibodies. 
Table of antibodies used for western blot analysis.  
CST = Cell Signaling Technologies. TF = ThermoFisher.  






Table 3. Taqman probes used for qPCR.  
All probes were purchased from ThermoFisher. Mouse gene probe catalog number begins 







CHAPTER THREE – GENETIC AND DIET-INDUCED METABOLIC 
DYSFUNCTION LEADS TO ADIPOSE TISSUE REMODELING IN 
PERIGONADAL ADIPOSE TISSUE 
  
The data in this chapter were acquired in collaboration with Sylvie Perez (Pfizer, 
Cambridge, MA) and Rushi Patel (Pfizer, Cambridge, MA). Sylvie harvested the plasma 
and tissues from the mice. She also measured the circulating parameters in the plasma. 
Rushi extracted RNA from the adipose depots.  Preparation of cDNA, gene expression 
analysis, data organization, statistical analysis and figure generation was done by the 
author of this thesis. 
Introduction 
Obesity in adults continues to rise in the developed world partly due to increased 
caloric intake and decreased energy expenditure 1. During times of overnutrition or 
caloric excess, the well-known role of adipose tissue is to store the excess calories 
through either expansion of lipid droplets, a process known as hypertrophy, or by 
increasing adipocyte number, a process referred to as hyperplasia 105. During times of 
adipose tissue growth, the adipose tissue undergoes remodeling 28. The role of the 
extracellular matrix (ECM) is to provide the cells within the adipose tissue with structural 
strength and mechanical protection from external forces 66. Metabolic dysfunction arises 
when the healthy balance of ECM remodeling becomes imbalanced with a net increase, 
leading to adipocyte dysfunction and fibrosis 70,71. The long-term goal of my project is to 




weight gain to help identify potential targets for therapeutics against obesity-related 
metabolic diseases.  
There have been many mouse models of obesity and insulin resistance 
characterized and published in the literature. These models are either genetically-induced 
or diet-induced, typically through the feeding of high fat diet 129,130. Strissel and 
colleagues demonstrated in a diet-induced model that over a time course up to 20 weeks 
of high fat diet (60% of calories from fat) feeding, C57BL/6 mice become obese, develop 
insulin resistance and the adipose tissue undergoes dramatic remodeling during this time 
period 80. In addition, deletion of col6 in mice with an ob/ob background (col6KOob/ob) 
rescued them from becoming metabolically dysfunctional in part to the increased ability 
of the adipose tissue to continue to undergo healthy expansion and remodeling during the 
progression to an obese state 131. Mice harboring the ob/ob mutation lack the capacity to 
produce the satiating adipokine, leptin, and are therefore voracious eaters and become 
obese on a standard chow diet 22,130. 
In order to decide which model would be the most appropriate to study adipose 
tissue remodeling during the progression of metabolic dysfunction, we evaluated both a 
diet-induced (60% HFD) and a genetically-induced (ob/ob ) mouse model of metabolic 
dysfunction. We measured circulating plasma parameters and gene expression of 
remodeling, inflammatory and fibrosis markers in subcutaneous and perigonadal adipose 
depots in both at a single, intermediate time point of approximately 11 weeks.  
Our results establish that both mouse models developed differing degrees of 




parameters. The perigonadal depot appeared to respond more dynamically to the 
metabolic challenges with elevated expression of the majority of adipose tissue 
remodeling, inflammation and fibrosis markers measured compared to the subcutaneous 
adipose depot. 
Results 
 After 11 weeks of high fat diet (HFD) feeding, the HFD group had similar plasma 
glucose and elevated insulin, although did not reach significance, compared to wildtype 
C57BL/6J chow diet (CD) control group. In the genetically-induced ob/ob model, both 
glucose and insulin levels were significantly elevated compared to C57BL/6J CD group 
(Table 4). Circulating non-esterified fatty acids (NEFA), a marker of lipolysis, did not 
change between any of the groups. Beta-hydroxybutyrate (BHBA), a marker of NEFA 
oxidation in the liver during fasting 132, was significantly decreased in the ob/ob mice 
(Table 4). Plasma triglycerides trended upwards in the ob/ob mice but did not reach 
significance when compared to the C57BL/6J CD group. Both high and low density 
lipoproteins, HDL and LDL respectively, were significantly elevated in HFD and ob/ob 
groups (Table 4). Circulating markers of liver damage, aspartate aminotransferase (AST) 
and/or alanine aminotransferase (ALT), were also elevated in both groups (Table 4). 
 Given the evidence of metabolic dysfunction as determined by plasma 
biochemistry, we next evaluated subcutaneous and perigonadal adipose depots for mRNA 
expression of adipose remodeling, inflammation and fibrosis markers (Figure 2). 





Table 4. Plasma biochemistry. 
Plasma was harvested from mice after an overnight fast. N=5-6 mice per group. 
Means +/- SEM. Statistical comparisons made back to control C57BL/6J (11 weeks 
CD) group are marked with an asterisk (*) when deemed significant. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001. Statistical comparisons made between 
C57BL/6J 11 weeks HFD and ob-/ob- groups are marked with a hashtag (#) when 
deemed significant. #p<0.05, ##p<0.01, ###p<0.001, ####p<0.0001. All comparisons 
were made using one-way ANOVA controlling for false discovery rate (FDR<0.05) 






Figure 2: Perigonadal adipose tissue has increased mRNA expression of 
extracellular matrix and inflammatory markers in both diet and genetically-induced 
obesity mouse models. 
Wildtype C57/Bl6 mice were fed chow diet (CD; blue) or high fat diet (HFD; orange) 
for 11 weeks starting from 6 weeks of age. C57/Bl6 ob/ob mice (purple) were fed 
CD starting from 6 weeks of age until 10-12 weeks of age. SQWAT = subcutaneous 
adipose tissue. PGWAT = perigonadal adipose tissue. N=5-6 mice per group. Data 
are represented in box and whisker plots. Statistical analysis was done using one-
way ANOVA controlling for false discovery rate (FDR<0.05) with Two-stage step-up 
method of Benjamini, Krieger and Yekutieli and comparing groups back to CD within 





 (SQWAT) were Col4a1, a component of the basement membrane, and Tnfa a 
proinflammatory cytokine. Furthermore, these markers were only changed in the 
SQWAT of the ob/ob group compared to the C57BL/6J CD group (Figure 2). Col4a1 
was also significantly upregulated in the perigonadal adipose depot (PGWAT) of the 
ob/ob group (Figure 2). Both COL4A1 and TNFA expression have been positively 
correlated with insulin resistance in human adipose tissue133,134.  Both of the other 
collagens measured, Col1a1 and Col6a1, were significantly elevated in the PGWAT of 
HFD and ob/ob groups compared to C57BL/6J  CD group (Figure 2). Inflammatory 
cytokines Tgfb1, Tnfa and macrophage marker Cd68 were all significantly elevated in the 
PGWAT in HFD and ob/ob groups (Figure 2). MRTFA (mkl1) expression, which has 
been shown to play a role in adipose tissue fibrosis 104, was significantly elevated in 
PGWAT in both HFD and ob/ob groups whereas its target gene, α-SMA (Acta2), was 
unchanged (Figure 2). MRTFA is regulated post-translationally by actin as well as 
phosphorylation which could offer an explanation for the disconnect between mRNA 
expression and activity 135,136. Adiponectin expression (Adipoq), an adipokine that is 
inversely correlated with obesity 26, was dramatically decreased in the PGWAT of both 
model groups (Figure 2). 
Discussion 
The aim of this experiment was to evaluate two mouse models of obesity and 
metabolic dysfunction for the capacity of adipose tissue remodeling at a single time point. 
We compared a diet-induced model (60% HFD) and a genetically-induced model (ob/ob) 




plasma parameters revealed significant increases in metabolic endpoints in both models 
when compared to C57BL/6J CD suggesting that both models had reached a state of 
metabolic dysfunction. Both models appeared to have decreased insulin sensitivity, as 
shown by elevated insulin and/or glucose levels compared to the C57BL/6J CD group. 
Unsurprisingly, the glucose and insulin values from the ob/ob group indicate that these 
mice had severely impaired insulin sensitivity compared to C57BL/6J HFD group. The 
ob/ob mouse is a much faster model for the induction of metabolic dysfunction compared 
to a HFD-induced model 137. It became apparent based on the mRNA markers measured, 
that the perigonadal adipose depot undergoes more dynamic changes to ECM and 
inflammatory genes, compared to the subcutaneous depot, suggesting that it is actively 
remodeling after approximately 11 weeks of study duration.  
Overall, both mouse models of metabolic dysfunction lead to changes in markers 
of tissue remodeling however to different extents. Based on these data, we can conclude 
that using a 60% HFD-induced mouse model would be more suitable to study the 
dynamics of adipose tissue remodeling over an extended time course. The ob/ob model, 
with its extreme hyperphagic phenotype, would not be suitable for our studies as the 
progression to obesity and insulin resistance is far too fast. In addition, the HFD-induced 
mouse model is thought to better mimic human progression of obesity, metabolic 
dysfunction and development of type 2 diabetes and associated co-morbidities such as 
NAFLD 138. Thus for our next study, we will focus on the perigonadal adipose depot and 
use a 60% HFD diet-induced model for our investigation into the dynamics of adipose 




CHAPTER FOUR – DIFFERENTIAL RESPONSE OF ADIPOSE TISSUE CELLS 
TO CHRONIC OBESOGENIC ENVIRONMENT 
  
Abstract 
Insulin resistance, which precedes diseases such as NAFLD, type 2 diabetes and 
cardiovascular complications 5,6, arises when the healthy balance of adipose tissue 
remodeling during expansion becomes dysregulated, leading to adipocyte dysfunction 
and fibrosis 70,71. The goal of this study was to evaluate isolated adipocytes and SVF cells 
in the perigonadal adipose tissue in response to an obesogenic, high fat diet over a time 
course of 8, 20 and 34 weeks. My data show that the perigonadal adipose depot expands 
in response to high fat diet (HFD) and had reached a plateau by 8 weeks. When taking a 
closer look at the cell fractions, dynamic transcriptional changes are revealed over the 
time course up to 34 weeks. Furthermore, the adipocytes and SVF cells demonstrate a 
differential pattern of remodeling gene expression in response to HFD which revealed a 
strong influence of aging. These data provide a novel insight into the remodeling 
responses of the adipose tissue fractions to a chronic obesogenic stimulus. 
Introduction 
Obesity 
Obesity in people of all ages post infancy continues to rise in the developed world 
partly due to increased intake of calorically dense food and decreased activity levels 1-3. 
Obesity is characterized by accumulation of adipose tissue as a well-known role of 




resistance, which precedes diseases such as NAFLD, type 2 diabetes and cardiovascular 
complications 5,6, arises the dysregulation of remodeling which ultimately leading to 
adipocyte dysfunction and fibrosis 70,71. Furthermore, obesity is not only present with 
excess nutrition but has also become a disease of the elderly 139.   
Adipose tissue remodeling and fibrosis 
Healthy adipocytes maintain a remarkably high degree of plasticity; quickly 
responding to whole body energy demands either through the release of fatty acids and 
glycerol, storage of excess calories as triglycerides and/or secretion of adipokines. The 
unique ability of the adipocyte to regulate its size through dynamic expansion or 
shrinkage requires continual remodeling of the tissue environment, specifically the 
extracellular matrix (ECM) 64-67. The ECM is an important component of adipose tissue 
as it provides adipocytes with structural support and protection from mechanical stresses 
as well as serving as a reservoir of growth factors and cytokines 140-142. 
Remodeling in healthy adipose tissue involves the continuous turnover of ECM 
proteins such as collagen, fibronectin and various others by a cycle of matrix deposition 
by adipocytes and other SVF cells and degradation by enzymes such as 
metalloproteinases (MMPs) 68.  The maintenance of a pliable ECM is necessary to 
maintain the homeostasis of the tissue through the unrestricted expansion and contraction 
of adipocytes 64,65. In addition to ECM turnover, angiogenesis within the fat pad keeps up 
with the expansion rate during healthy remodeling, ensuring that the tissue remains well 
oxygenated 69. Maintaining a flexible ECM is also necessary to allow for adipocyte 




Increased deposition of ECM and decreased degradation or turnover occurs, 
combined with an increase in crosslinking and stiffening of ECM fibers ultimately 
leading to adipocyte dysfunction, reduced adipogenic capacity and fibrosis with all 
contributing to whole body metabolic dysfunction 70,71. Indeed, deletion of collagen 6 
(col6), a component of the ECM that has enriched expression in adipose tissue, resulted 
in improved glucose tolerance and decreased liver triglycerides when challenged with an 
ob/ob background or a high fat diet 131. 
Macrophages which reside in the stromal vascular fraction play a role in 
angiogenesis through the secretion of matrix degrading enzymes matrix 
metalloproteinases (MMPs) such as MMP-9 and stimulation of angiogenesis via VEGF 
74,143. It is well understood that as obesity develops and the adipose tissue continues to 
expand, there is an increased density of macrophages as well as other immune cells into 
adipose tissue 75,76. At the simplest interpretation, macrophages can be divided into 2 
classes, M1 and M2, based on their inflammatory profile as being predominantly pro- or 
anti-inflammatory. Macrophages play an important role in adipose tissue remodeling 
through the clearance of debris and lipids released from the deceased adipocyte 81. 
Strissel and colleagues reported that after 16 weeks of HFD feeding a massive influx of 
macrophages and a striking degree of adipocyte death, which lead to increased and near 
complete remodeling of perigonadal adipose depot 80. Thus highlighting the capacity of 
the perigonadal adipose depot to remodel but also of the role of cells within the SVF in 




The goal of this study was to evaluate the isolated adipocytes and SVF cells in the 
perigonadal adipose tissue in response to high fat diet feeding over a time course of 8, 20 
and 34 weeks. My data show that the perigonadal depot expands in response to high fat 
diet (HFD) and reached a plateau by 8 weeks. Furthermore, the adipocytes and SVF cells 
demonstrate a differential pattern of remodeling gene expression in response to HFD 
uncovering a strong influence of aging. 
Results 
Diet and aging-induced obesity leads to metabolic impairment over 34 weeks 
To begin to evaluate adipose tissue remodeling in the context of weight gain and 
progression of obesity, I used a 60% high fat diet-induced mouse model of obesity over a 
time course of 8, 20 and 34 weeks. During the study, mice fed a high fat diet (HFD) 
gained significantly more weight compared to chow diet (CD) control groups at all time 
points (Figure 3A). After 34 weeks of HFD, the mice had modestly increased lean mass 
and strikingly nearly twice the fat mass as the CD group (Figure 3A). To gain insight 
into the metabolic health of the mice, fasting plasma glucose and insulin were measured. 
Mice fed HFD had a transient but insignificant increase in fasting glucose at the 8 week 
time point that normalized by 34 weeks (Figure 3B). Fasting insulin levels were 
significantly elevated in the HFD group at all time points compared to CD groups 
(Figure 3B). Interestingly, 34 weeks of CD resulted in significantly increased fasting 
insulin compared to earlier time points suggesting an effect of aging-induced obesity on 





Figure 3: High fat diet feeding over the course of 34 weeks leads to increased 
bodyweight and metabolic impairment.  
A) High fat diet (HFD) feeding over the course of 34 weeks resulted in significantly 
increased bodyweight compared to chow diet (CD). At 34 weeks, body composition 
was measured using EchoMRI to determine relative fat and lean mass. B) HFD fed 
mice displayed modestly and transiently increased fasting glucose. Fasting insulin 
levels were significantly increased with HFD compared to CD at all time points. 
Means ± SEM. Comparisons between groups and statistical analysis done with two-
way ANOVA controlling for false discovery rate (FDR<0.05) with Two-stage step-up 
method of Benjamini, Krieger and Yekutieli or unpaired t-tests with two-tailed p-




Evidence of the impact of aging on circulating lipids 
Evaluation of other circulating parameters related to adipocyte function and 
metabolic health revealed subtle differences (Table 5). Fasting plasma triglyceride 
concentrations did not differ between diet groups over the time course of the study. 
However, triglyceride levels were significantly increased at the 34 week time point 
within each respective diet compared to the starting 8 week time point suggesting an 
aging-related and not a diet effect (Table 5). Circulating cholesterol was significantly 
increased in HFD compared to CD at all time points (Table 5). Interestingly, after 34 
weeks, plasma cholesterol was also significantly higher in the CD group compared to 
earlier CD time points (Table 5). Plasma NEFAs were significantly decreased with HFD 
feeding at all time points compared to CD. Glycerol was significantly increased after 20 
weeks HFD. Within each diet, plasma glycerol levels were increased after 34 weeks 
compared to 8 weeks (Table 5). Lactate levels were significantly increased after 34 
weeks HFD compared to 34 week CD group. Lactate levels were significantly elevated 
within each diet group at the 34 week time point when comparing back to 8 weeks group 
(Table 5). 
Obesity and adipose tissue expansion are coupled with increased liver weight and 
dysregulated adipokines. 
 After 8 weeks of HFD, both the subcutaneous and perigonadal adipose depot 
weights were significantly increased compared to CD (Figure 4A). At 20 and 34 week 





Table 5. Plasma biochemistry 
Plasma was harvested from mice after a 6 hour fast. N=5-8 mice per group. Means 
+/- SEM. Statistical comparisons between chow diet (CD) and high fat diet (HFD) 
groups within the same time point are marked with an asterisk (*) when deemed 
significant. *p<0.05, **p<0.01, ****p<0.0001. Statistical comparisons to 8 weeks 
time point made within each diet group are marked with a hashtag (#) when 
deemed significant. #p<0.05, ##p<0.01, ###p<0.001, ####p<0.0001. All comparisons 
were done using two-way ANOVA controlling for false discovery rate (FDR<0.05) 






Figure 4: Increased bodyweight is accompanied with elevated adipose and liver 
tissue weight as well as circulating markers of liver damage after 34 weeks. 
A) Subcutaneous adipose, perigonadal adipose and liver tissue weights of chow diet 
(CD) or high fat diet (HFD) fed mice over a course of 34 weeks. B) Plasma liver 
enzymes aspartate transaminase (AST) and alanine transaminase (ALT) in CD and 
HFD mice over 34 weeks. All tissues and plasma were collected after a 6 hour fast. 
N=5-8 mice per group. Means +/- SEM. Comparisons between groups and statistical 
analysis done with two-way ANOVA controlling for false discovery rate (FDR<0.05) 
with Two-stage step-up method of Benjamini, Krieger and Yekutie. *p<0.05, 





 weight whereas the perigonadal adipose depot reached a plateau at 8 weeks (Figure 4A). 
This is not surprising as the perigonadal adipose depot has been shown to rapidly 
increase, doubling in size, after just one week of high fat feeding 144. Furthermore, this 
plateau after 8 weeks HFD feeding  is also consistent with a published time course study 
of HFD feeding80. By 34 weeks, the CD perigonadal depot was a similar weight 
compared to the 8 weeks HFD group (Figure 4A). Liver weight increased by 
approximately 2-fold after 34 weeks of HFD (Figure 4A). In concordance with increased 
liver weight, circulating markers of liver damage, ALT and AST, were also significantly 
increased (Figure 4B). Circulating leptin was found to be increased in a similar pattern to 
subcutaneous adipose tissue expansion (Figure 5). This is in agreement with the 
literature as leptin has been shown to positively correlate with obesity 24,145. Conversely, 
adiponectin was significantly decreased in total perigonadal adipose tissue after 20 and 
34 weeks HFD compared to CD at the same time points (Figures 6A and 6B). This is 
also in agreement with published studies showing that adiponectin levels are negatively 
correlated with obesity 146.  
Increased adipocyte size and appearance of crown-like structures coincides with 
ectopic lipid accumulation  
 Hematoxylin and eosin (H&E) staining of perigonadal adipose tissue cross-
sections reveal increased adipocyte size after 8 weeks HFD. Evidence of remodeling in 
the stromal vascular compartment with increased cell density surrounding adipocytes in 
the HFD group became apparent after 8 weeks and continued to progress throughout the 





Figure 5: Circulating plasma leptin increased with increased body weight and fat 
mass. 
Plasma was collected after a 6 hour fast. N=5-8 mice per group. Means +/- SEM. 
Comparisons between groups and statistical analysis done with two-way ANOVA 
controlling for false discovery rate (FDR<0.05) with Two-stage step-up method of 






Figure 6: Adiponectin content decreased in perigonadal adipose tissue after 20 and 
34 weeks of high fat diet feeding. 
A) Western blot of perigonadal adipose tissue (PGWAT) lysates from chow diet (CD) 
and high fat diet (HFD) at 8, 20 and 34 week time points. B) Densitometry analysis 
of protein expression normalized to cyclophilin A (CypA) loading control. N=3 mice 
per treatment group and time point. Data are represented as means ±SEM. Two-way 
ANOVA controlling for false discovery rate (FDR<0.05) with Two-stage step-up 
method of Benjamini, Krieger and Yekutie. *p<0.05, **p<0.01, ***p<0.001, 






Figure 7: Increased perigonadal adipocyte size, cell infiltration and ectopic lipid 
accumulation progressing over 34 weeks. 
A) Hematoxylin and eosin staining (H&E) of cross-section of perigonadal adipose 
tissue from chow diet (CD) or high fat diet (HFD) fed mice after 8, 20 and 34 weeks. 
B) Hematoxylin and eosin staining (H&E) of cross-section of liver tissue from chow 
diet (CD) or high fat diet (HFD) fed mice after 8, 20 and 34 weeks. All images taken 




adipocytes resemble crown-like structures (CLS) in which macrophages surround dying 
adipocytes, however without probing with macrophage markers, it cannot be definitely 
concluded. Macrophage-positive CLS surrounding adipocytes were shown to be 
increased in the visceral adipose tissue from obese mice and humans 81,147. Notably, the 
increased size of adipocytes as well as appearance remodeling in the SVF was also 
apparent in the 34 week CD group compared to earlier time points (Figure 7A). In 
agreement with declining adipocyte function, after 8 weeks HFD, ectopic lipid 
accumulation can be seen in H&E stained liver cross-sections (Figure 7B). By 34 weeks 
of HFD, significant lipid accumulation can be seen in the liver suggesting that the organ 
had developed steatosis (Figure 7B). Notably, 34 week CD mice also had evidence of 
time-associated decline in hepatic health with apparent hepatocyte ballooning and lipid 
accumulation (Figure 7B).  
Increased extracellular matrix in perigonadal adipose tissue with chronic high fat diet. 
To evaluate the extracellular matrix (ECM) in the perigonadal adipose tissue 
(PGWAT), I stained cross-sections with picrosirius red stain which detects collagen, a 
primary component of the ECM 109,142. Increased pericellular collagen staining was 
apparent after 20 and 34 weeks HFD (Figure 8A). 34 weeks CD mice also had increased 
staining surrounding the larger adipocytes in the PGWAT (Figure 8A). I also stained 
cross-sections of PGWAT for elastin, another component of the ECM 71. Elastin staining 
in the HFD groups was similar to collagen staining with increased staining intensity over 
the time course of the study (Figure 8B). Interestingly, both collagen and elastin staining 





Figure 8: High fat diet feeding over 34 weeks leads to enhanced extracellular matrix 
staining in perigonadal adipose tissue. 
A) Picrosirius red staining (detecting collagen) of cross-section of perigonadal 
adipose tissue from chow diet (CD) or high fat diet (HFD) fed mice after 8, 20 and 34 
weeks. B) Elastica van Gieson staining (detecting elastin) of cross-section of liver 
tissue from chow diet (CD) or high fat diet (HFD) fed mice after 8, 20 and 34 weeks. 





 obvious SVF remodeling, the macrophage-enriched crown-like structures surrounding 
the dying adipocytes. It has been shown that adipose tissue macrophages associate with 
elastin fibers and that macrophages are the predominant producers of MMP-12, a 
degrading enzyme for elastin, suggesting that macrophages play an active role in elastin 
remodeling 148. Curiously, there appeared to be a transient increase in overall elastin 
staining in the 20 week CD group (Figure 8B). This is interesting because it occurred 
before the tissue went on to nearly triple in weight by the 34 week time point, perhaps 
suggesting a time of remodeling in response to an unknown stimulus. 
Adipocytes upregulate expression of extracellular matrix genes in response to high fat 
diet. 
 Based on the increased extracellular matrix staining seen in the cross-sections of 
perigonadal adipose tissue, I next evaluated gene expression of ECM remodeling markers 
in isolated stromal vascular fraction cells (SVF) and isolated adipocytes from all groups. I 
plotted the data as log2FC from 8 week CD group within each fraction to evaluate the 
response of the different tissue fractions to diet as well as time. Starting with the SVF 
cells, the response to HFD as well as time in the SVF was strikingly similar (Figure 9A). 
Expression of collagens (col1a1, col4a1, col6a3) and fibronectin (fn1) were similarly 
upregulated in SVF from CD and HFD groups at 34 weeks (Figure 9A). Tissue 
remodeling enzymes mmp2, mmp9, mmp11 and timp1 expression was similar between 
the diet groups (Figure 9A). TGF-β1 (tgfb1), its receptors (tgfbr1, tgfbr2) as well as 
expression of its target genes (itga5, acta2, ctgf, serpine) were all similarly expressed in 





Figure 9: Stromal vascular fraction cells regulation of extracellular matrix 
components gene expression is similar in response to high fat diet-induced or age-
induced obesity. 
Gene expression of ECM remodeling and fibrosis markers in A) SVF cells and B) 
isolated adipocytes as measured by qPCR. Data are represented as log2 fold change 
(Log2FC) from 8 week chow diet (CD) group. Heat map colors represent median 





 measured that was more strongly upregulated in response to high fat compared to CD in 
SVF was tnc. Tnc is a pro-fibrotic glycoprotein that has been shown to contribute to 
tissue remodeling and fibrosis through its interaction with toll-like receptor 4 (TLR4), a 
receptor associated with pro-inflammatory responses 149-152.  
In contrast to SVF cells, isolated adipocytes responded strongly to high fat 
stimulus compared to CD. Expression of collagens (col1a1 and col6a3), fibronectin (fn1) 
were strongly upregulated in adipocytes from HFD PGWAT starting at 8 weeks and 
progressing to 34 weeks compared to CD adipocytes (Figure 9B). Expression of matrix 
metalloproteinases, mmp2 and mmp11, were elevated in response to HFD however a 
tissue inhibitor of metalloproteinases, timp1, displayed a similar expression pattern for 
diet and time (Figure 9B). Tgfb1, inhba, itga5 and ctgf were all strongly upregulated in 
response to HFD at 20 and 34 week time points compared to CD (Figure 9B). In contrast 
to SVF, tnc was strongly downregulated in the aged adipocytes independent of high fat 
stimulus. 
Isolated adipocytes display similar expression of inflammatory cytokines in response to 
high fat diet and time. 
 Next I measured gene expression for markers of inflammation and angiogenesis 
in SVF and adipocyte fractions. Strikingly, again the SVF displayed a similar pattern of 
expression between the diet groups instead appearing to respond strongly to time rather 
than high fat (Figure 10A). Pro-inflammatory cytokines (ccl2, tnfa and il-6) as well as 
anti-inflammatory cytokine, il-10, were upregulated with time in SVF from both CD and 





Figure 10: Stromal vascular cells and adipocytes have similar inflammatory 
cytokine expression in response to high fat diet-induced or age-induced obesity. 
Gene expression of inflammatory markers in A) SVF cells and B) isolated adipocytes 
as measured by qPCR. Data are represented as log2 fold change (Log2FC) from 8 






marker, pdgfra 57, were also upregulated with time in both CD and HFD SVF groups 
(Figure 10A). Macrophage markers mrc1 (CD206), adgre1 and arg1 were upregulated 
with time in both CD and HFD SVF groups (Figure 10A). Angiogenesis marker, vegfa, 
and hypoxia sensor, hif1a, expression were also upregulated with time in CD and HFD 
SVF groups (Figure 10A). 
 Interestingly, in contrast to the ECM remodeling genes, the isolated adipocytes 
had similar expression patterns between CD and HFD for inflammatory adipokines ccl2, 
tnfa and il-6 (Figure 10B). As expected, adiponectin expression, adipoq, decreased with 
HFD feeding over time up to 34 weeks (Figure 10B). In contrast to the SVF, vegfa and 
hif1a expression were decreased or unchanged in the adipocyte fraction (Figure 10B).  
Discussion 
The goal of this study was to gain insight into perigonadal adipose tissue 
remodeling in the presence of high fat diet feeding over an extended time course of 8, 20 
and 34 weeks. These time points were chosen to encompass those used in the literature (8 
and 20 weeks)80,104 as well as to extend the study a little bit longer to 34 weeks. I took the 
approach to fractionate the perigonadal adipose tissue which allowed me to examine the 
remodeling response of the SVF cells and isolated adipocytes separately. 
In line with previously published data with similar HFD feeding endpoints, we 
observed increased bodyweight and fasting insulin levels paired with similar fasting 
glucose levels suggesting that the HFD fed mice were becoming less insulin sensitive 80. 
Hematoxylin and eosin (H&E) staining also revealed remodeling of the stroma vascular 




By 34 weeks of HFD feeding, the liver had extensive lipid accumulation and as such had 
developed steatosis,. An unexpected observation was the effect of aging on hepatic health 
in the 34 week CD group with mild lipid accumulation and hepatocyte ballooning 
evident. Adipokine content was also found to be dysregulated with elevated circulating 
leptin and decreased adiponectin in PGWAT, collectively suggesting a decline in 
metabolic function. The 34 week CD group displayed elevated leptin levels in accordance 
with increased bodyweight and fat mass however the adiponectin measured in the 
PGWAT was unchanged over the time points. This result was complimented with a 
similar pattern of decline of adiponectin RNA (adipoq) in isolated adipocytes from 
PGWAT. This suggests an effect of the HFD on adiponectin production in the PGWAT. 
TNF-α secretion from adipose tissue has been shown to positively correlate with obesity 
and insulin resistance and inversely correlate with plasma adiponectin 154. Furthermore, 
TNF-α has been shown to negatively regulate adiponectin through multiple mechanisms 
including the suppression of ER chaperone proteins as well as through the suppression of 
PPAR-γ, which adiponectin is a target gene of, in adipocytes 155,156. 
Evaluation of the fractionated adipose tissue for markers of ECM remodeling and 
inflammation painted an intriguing picture. During the course of HFD from 8 to 34 
weeks, the expression of the ECM and inflammatory-associated genes assayed in SVF 
was remarkably similar between the CD and HFD groups. Thus suggesting that the cells 
within the SVF at each time point were not responding as strongly to high fat stimulus as 
they were to maturation. These results were sharply contrasted when then looking at the 




responding to the high fat stimulus through the upregulation of ECM markers compared 
to control CD. Curiously, expression of inflammatory markers in the adipocyte fraction 
appeared to be modulated more by time than diet. This suggests a temporal response of 
adipocytes modulating the ECM in response to HFD stimulus after 8 weeks. Between 8 
and 20 weeks, cells of the SVF respond to the change in ECM from the adipocytes with 
an upregulation of inflammatory cytokines and ECM remodeling genes. This continues 
through to the 34 week time point as the expression of ECM remodeling and 
inflammation genes in both fractions climb or remain elevated.  
Collectively, my data give a novel insight into the transcriptional response of 
isolated SVF and adipocytes to HFD feeding over an extended time course up to 34 
weeks. Interestingly, I observed a strong response to time in the SVF in regards to 
remodeling in contrast to the adipocytes which responded with an upregulation of matrix 
remodeling genes in response to high fat diet stimulus. These results are striking because 
the two cell compartments, SVF and adipocytes, are sharing the same environment and 
are exposed to presumably the same stimuli, yet they are responding very differently. The 
SVF is a heterogeneous cell population whose identify changes in response to different 
stimuli which may explain the differential response pattern 157. These data provide an 
introduction into the overall picture of the responses of the adipose tissue fractions to an 
obesogenic stimulus. Evaluating the whole transcriptome using RNA-seq would provide 
valuable insight into the pathways that are changing globally in particular those specific 




CHAPTER FIVE – EVALUATION OF ADIPOCYTES TRANSCRIPTIONAL 
SIGNATURE IN RESPONSE TO HIGH FAT DIET-INDUCED REMODELING 
 
Differential gene expression analysis of the RNA-seq data in this chapter was 
analyzed in collaboration with Joseph Orofino and Dr. Valentina Perissi (Boston 
University) as well as Dr. Ramya Gamini (Pfizer Inc). The author of this thesis performed 
all sample preparation, raw data generation, post pathway analysis and all figure 
generation. 
Abstract 
Obesity in adults continues to rise in the developed world partly due to increased 
caloric intake and decreased energy expenditure 1. During periods of adipose tissue 
growth, the adipose tissue undergoes remodeling 28. Remodeling of the tissue to 
accommodate the expansion is vital, otherwise metabolic dysfunction and comorbidities 
such as type 2 diabetes and cardiovascular complications arise when remodeling becomes 
dysregulated, leading to adipocyte dysfunction and fibrosis 70,71. In this study, I took a 
focused view on the specific transcriptional changes within adipocytes. My data 
demonstrate that the adipocyte plays an active role in remodeling through the 
upregulation of ECM-related genes and pathways in response to high fat diet. The 
detrimental impact of high fat diet feeding on adipocyte mitochondria was also apparent 
with decreased expression of mitochondrial-related genes, decreased OXPHOS proteins 




pathways within the adipocyte in response to an obesogenic and increasingly tense 
microenvironment. 
Introduction 
Healthy adipocytes maintain a high degree of plasticity; quickly responding to 
whole body energy demands either through the release of fatty acids and glycerol for use 
as fuel by other organs, storage of excess calories as triglycerides and/or secretion of 
adipokines. The extracellular matrix surrounding the adipocyte plays an important role in 
an adipocyte’s ability to rapidly expand 64-67. Aside from providing structural support, the 
ECM is an important component of adipose tissue as it serves as a reservoir of growth 
factors and cytokines 140-142.  
Remodeling in healthy adipose tissue involves the continuous turnover of ECM 
proteins such as collagen, fibronectin and various others by a cycle of matrix deposition 
by adipocytes and other SVF cells and degradation by enzymes such as metalloproteases 
(MMPs) 68.  This continuous cycle of ECM renewal is necessary to maintain the function 
of the tissue through the unrestricted expansion and contraction of adipocytes 64,65. In 
addition to ECM turnover, angiogenesis within the fat pad keeps up with the expansion 
rate during healthy remodeling, ensuring that the tissue remains well oxygenated 69. 
Maintaining a flexible and uncompressed ECM is also necessary to allow for adipocyte 
progenitor cells to traverse to areas where new adipocytes are required 66. Increased 
deposition and density of ECM coupled with an increase in crosslinking of ECM fibers 




Mitochondria are the powerhouse of the cell, generating ATP and other metabolic 
intermediates to support cell function. In comparison to brown adipocytes and other 
metabolically active cells, white adipocytes have relatively low density of mitochondria 
per cell 158. However, each of those mitochondria plays a vital role in supporting the 
many aspects of white adipocyte function such as lipogenesis, TG synthesis, lipolysis and 
adipokine secretion 128,159,160. Moreover, it has been demonstrated that the endoplasmic 
reticulum (ER) and mitochondrion share connections and thus have the capacity to 
communicate directly 161. This connection becomes important in the context of metabolic 
dysfunction, insulin resistance and T2D as both ER stress and mitochondrial dysfunction 
have been shown to be involved in disease progression 162. Mitochondrial dysfunction in 
adipocytes results from the decreased capacity to generate sufficient ATP quantities 
required for maintenance of adipocyte function thus resulting in diminishing participation 
to overall metabolic homeostasis 160,163.  
 The goal of this study was to evaluate the transcriptional response to HFD-
induced remodeling in isolated adipocytes. My data demonstrates that adipocytes respond 
to a HFD stimulus by upregulating extracellular matrix-related genes and pathways such 
as collagens, elastin and TGF-β1. In addition, prolonged high fat diet feeding lead to the 
downregulation of mitochondrial related genes and pathways as well as the upregulation 
of markers associated with ER stress suggesting a stress-related decline in adipocyte 
health. Mitochondrial OXPHOS complexes and lipolytic enzyme proteins were also 




transcriptional changes happening within adipocytes in response to high fat diet stimulus 
in terms of ECM remodeling, fibrosis as well as in regards to the health of the cell. 
Results 
Adipocytes exert a dynamic transcriptional response to high fat diet stimulus. 
To take an in-depth look at the transcriptional changes occurring in the different 
fractions of the perigonadal adipose tissue, I conducted RNA-seq analysis on the isolated 
stromal vascular fraction (SVF) and adipocytes of chow diet (CD) and high fat diet 
(HFD) fed mice over 8, 20 and 34 week time points. Starting with a high-level view, I 
made volcano plots of the differentially expressed genes in the SVF comparing HFD to 
CD at each time point (Figure 11A). After 8 weeks of HFD, the number of differentially 
expressed genes in the SVF in response to HFD was limited to a few hundred (Figures 
11A and 11C). Interestingly after 20 weeks of HFD the number of DEGs substantially 
increased in the SVF cell compartment before then overall decreasing at the 34 week time 
point (Figures 11A and 11C). Strikingly, the adipocytes appeared to respond much more 
dynamically to a HFD. After 8 weeks of HFD, the number of DEGs in the adipocyte 
fraction was approximately 4000 genes (Figures 11B and 11D). After 20 weeks, the 
number of DEGs in the adipocyte fraction reached a maximum, as was seen in the SVF 
compartment, before modestly decreasing in total number by the 34 week time point 
(Figures 11B and 11D). Notably, the directionality of the DEGs and relative percentages 
of the total number differed between the two cell compartments. Overall, the SVF had a 








Figure 11: Differentially expressed genes in SVF and adipocyte fractions in response 
to high fat diet for 8, 20 or 34 weeks. 
Volcano plots of differentially expressed genes in high fat diet compared to chow 
diet in A) stromal vascular fraction or B) isolated adipocytes from the perigonadal 
adipose depot after 8 weeks (8w), 20 weeks (20w) and 34 weeks (34w).  Red = 
genes with adjusted p<0.05, orange = genes with logFC >1, green = genes with 
adjusted p<0.05 and logFC > 1. Total number and relative percentages of 
upregulated and downregulated differentially expressed genes in C) stromal 
vascular fraction and D) isolated adipocytes from perigonadal fat pad after high fat 




 which had a higher percentage of their total DEGs downregulated (Figures 11C and 
11D). 
Aged chow diet adipocytes cluster closer to high fat diet adipocytes.  
Principal component analysis of the isolated adipocytes revealed clustering of the 
diet groups and time points. This analysis allows a high level overview of identifying 
similarities and differences between the samples and groups in relation to how they 
cluster164 (Figure 12). 8 and 20 week CD samples clustered closely together and the 
groups partially overlapped, suggesting similarities between them (Figure 12). 8, 20 and 
34 week HFD samples clustered together within their respective groups and the groups 
near each other however there was no overlap between any of the groups (Figure 12). 
Thus suggesting that high fat was eliciting global transcriptional changes leading to high 
level differences between the groups at earlier time points compared to CD. Intriguingly, 
the 34 week CD samples clustered nearer the 8 and 34 week HFD groups than the 8 or 20 
week CD groups (Figure 12). This is in agreement with my phenotypic data, multiple 
metabolic parameters as well as protein data presented in chapter 4 that suggested to me 
that the 34 week CD was, in fact, resembling an earlier HFD time point, such as 8 weeks.  
Analysis of transcriptional changes specifically in adipocytes.  
Comparisons of the DEG lists were done to specifically look at the transcriptional 
changes that were unique to the adipocytes in the presence of HFD stimulus. An 
overview of the workflow is detailed in Figure 13. To focus in on changes occurring 





Figure 12: Principal component analysis of differentially expressed genes from 
isolated perigonadal adipocytes from chow diet (CD) or high fat diet (HFD) groups 
after 8, 20 or 34 weeks. 
Chow diet (CD) groups are closed circles. High fat diet (HFD) groups are open 
triangles. 8 week time point is red, 20 week time point is blue and 34 week time 





Figure 13: Overview of workflow for GO term pathway analysis.  
Analysis overview for selecting differentially expressed genes (DEGs) that are 




 and downregulated) from the SVF and adipocyte compartments in response to HFD 
compared to CD based on a padj<0.05 at each time point. Next, I overlaid the DEG lists 
from the SVF and adipocyte compartments at each time point to reveal genes that were 
differentially expressed only in the SVF (Figure 13, first row of Venn diagrams, green 
color), in the isolated adipocytes (Figure 13, first row of Venn diagrams, orange 
color) or in both compartments (Figure 13, first row of Venn diagrams, brown color) 
at each of the time points. Next, I took the lists of DEGs that were specifically changing 
in the isolated adipocytes from each of the 3 time points (Figure 13, first row of Venn 
diagrams, orange color) and overlaid them using a final Venn diagram (Figure 13, 
lower Venn diagram with 3 circles). This final comparison allowed me to identify 
DEGs that were differentially expressed across all time points (Figure 13, lower Venn 
diagram, bright green color) or specifically at each time point (Figure 13, lower Venn 
diagram, blue, pink and yellow colors). Once these lists were made, GO term 
enrichment analysis was done to determine the dominant pathways that were changing in 
the adipocytes in response to HFD at 8, 20 and 34 week time points as well as what 
pathways were in common over all time points (Figure 13). 
Upregulation of ECM and fibrosis-related genes and pathways in high fat diet 
adipocytes.  
GO term analysis of upregulated DEGs in adipocytes after HFD revealed 







Figure 14: Adipocytes upregulate extracellular matrix associated genes in response 
to high fat diet. 
Overlap of differentially expressed genes specifically upregulated in isolated 
adipocytes at 8, 20 and 34 weeks compared to SVF cells in high fat diet (HFD) 
groups. Number of DEGs present in each overlap is noted in Venn diagram. Top 15 
GO terms ranked by combined score using web-tool EnrichR124,125 for each time 
point or at the overlap of all time points. Genes were considered to be differentially 
expressed with an adjusted p-value <0.05 when comparing HFD to chow diet (CD) 
adipocytes or HFD to CD SVF. 8 week time point is represented in blue, 20 week 
time point is represented by pink, 34 week time point is represented by yellow and 





upregulated at each time point, 313 DEGs were maintained upregulated over all time 
points in response to high fat stimulus (Figure 14, green color). GO term analysis 
revealed enrichment of pathways related to actin binding, neutrophil mediated immunity, 
extracellular matrix organization, integrin binding and focal adhesion to name a few 
(Figure 14). Genes associated with GO terms in Figure 14 are listed in Tables 6, 7, 8 
and 9. Notably, pro-fibrotic cytokine TGF-β1 (Tgfb1) expression was found to be 
upregulated in adipocytes at all time points (Table 6). 8 weeks of HFD lead to 
upregulation of 772 genes which were associated with the endoplasmic reticulum (ER) 
and golgi as well as cell cycle and inflammation-related NIK/NF-kappaB signaling in 
adipocytes (Figure 14, blue color). Genes associated with the 8 week GO terms are listed 
in Table 7. By 20 weeks of HFD, adipocytes significantly upregulated 402 genes 
associated with extracellular matrix disassembly, ER lumen, positive regulation of cell 
migration and focal adhesion (Figure 14, pink color). Notably, multiple collagens 
(Col28a1, Col27a1, Col14a1, Col11a2, Col4a1, Col6a1), matrix degrader Mmp14 and 
matrix crosslinking enzyme Loxl1 were all upregulated specifically in adipocytes after 20 
weeks of HFD (Table 8). 34 weeks of HFD lead to 922 genes uniquely upregulated 
which equated to the enrichment of GO terms associated predominantly with regulation 
of cell cycle and mitosis (Figure 14, yellow color). Other terms significantly enriched 
were focal adhesion and lysosome (Figure 14, yellow color). Genes associated with the 







Table 6: GO terms and associated genes upregulated in isolated adipocytes after 8, 
20 and 34 weeks of high fat diet. 
Genes associated with top 15 GO terms upregulated in isolated adipocytes across all 
time points when comparing to HFD to CD and contrasted to upregulated genes in 
SVF cells. Go Aspect abbreviations: BP = Biological Processes, CC= Cellular 






Table 7: GO terms and associated genes upregulated in isolated adipocytes 
specifically after 8 weeks of high fat diet. 
Genes associated with top 15 GO terms upregulated in isolated adipocytes after 8 
weeks of high fat diet (HFD) compared to chow diet (CD) and contrasted to 
upregulated genes in SVF cells after 8 weeks. Go Aspect abbreviations: BP = 







Table 8: GO terms and associated genes upregulated in isolated adipocytes 
specifically after 20 weeks of high fat diet. 
Genes associated with top 15 GO terms upregulated in isolated adipocytes after 20 
weeks of high fat diet (HFD) compared to chow diet (CD) and contrasted to 
upregulated genes in SVF cells after 20 weeks. Go Aspect abbreviations: BP = 






Table 9: GO terms and associated genes upregulated in isolated adipocytes 
specifically after 34 weeks of high fat diet. 
Genes associated with top 15 GO terms upregulated in isolated adipocytes after 34 
weeks of high fat diet (HFD) compared to chow diet (CD) and contrasted to 
upregulated genes in SVF cells after 34 weeks. Go Aspect abbreviations: BP = 




Downregulation in mitochondrial genes and GO terms in high fat diet adipocytes.  
Adipocytes had a relatively similar number downregulated genes specific to each 
time point or comparison (Figure 15). Notably, 602 genes were downregulated at all time 
points and of these genes only 3 GO terms were significantly enriched, all of them related 
to mitochondria (Figure 15, green color). Genes associated with downregulated GO 
terms across all time points are listed in Table 10. After 8 weeks HFD treatment, 799 
genes were downregulated specifically at this time point (Figure 15, blue color). These 
genes enriched for GO terms primarily related to transcription and translation (Figure 15 
and Table 11). After 20 weeks of HFD 715 genes were downregulated, out of which 71 
were associated to the top enriched GO term mitochondria (Figure 15, pink color and 
Table 12). Other downregulated GO terms were building on the same theme seen at the 8 
week time point, downregulation of transcription and translation. After 34 weeks of HFD, 
878 were found to be specifically downregulated and GO terms associated with the 
mitochondrion became more prevalent including mitochondrion, mitochondrion inner 
membrane, mitochondrial translation elongation (Figure 15, yellow color). GO terms and 
genes associated with the proteasome were also significantly downregulated (Table 13).  
High fat diet adipocytes have reduced OXPHOS protein.  
Given the strong signal for the downregulation of mitochondrial-associated GO 
terms and genes and presumable dysfunction, I investigated the protein levels of the 
different complexes of the electron transport chain using whole PGWAT tissue lysates by 
western blot (Figure 16). After 8 weeks of HFD, decreases in mitochondrial complexes I, 





Figure 15: Mitochondrial related GO Terms are downregulated in adipocytes after 
high fat diet treatment. 
Overlap of differentially expressed genes specifically downregulated in isolated 
adipocytes at 8, 20 and 34 weeks compared to SVF cells in high fat diet (HFD) 
groups. Top significant GO terms ranked by combined score using web-tool 
EnrichR124,125 for each time point or at the overlap of all time points. Genes were 
considered to be differentially expressed with an adjusted p-value <0.05 when 
comparing HFD to chow diet (CD) adipocytes or HFD to CD SVF. 8 week time point is 
represented in blue, 20 week time point is represented by pink, 34 week time point 






Table 10: Mitochondrial related genes and GO terms downregulated across all high 
fat diet treatment time points. 
Genes associated with top GO terms downregulated in isolated adipocytes over 8, 20 
and 34 weeks of high fat diet (HFD) compared to chow diet (CD) and contrasted to 
upregulated genes in SVF cells at each time point. Go Aspect abbreviations: BP = 






Table 11: Adipocyte-specific downregulated GO terms at 8 weeks. 
Genes associated with top 15 GO terms downregulated in isolated adipocytes after 8 
weeks of high fat diet (HFD) compared to chow diet (CD) and contrasted to 
upregulated genes in SVF cells after 8 weeks. Go Aspect abbreviations: BP = 






Table 12: Adipocyte-specific downregulated GO terms at 20 weeks. 
Genes associated with top 15 GO terms downregulated in isolated adipocytes after 
20 weeks of high fat diet (HFD) compared to chow diet (CD) and contrasted to 
upregulated genes in SVF cells after 20 weeks. Go Aspect abbreviations: BP = 






Table 13: Adipocyte-specific downregulated GO terms at 34 weeks. 
Genes associated with top 15 GO terms downregulated in isolated adipocytes after 
34 weeks of high fat diet (HFD) compared to chow diet (CD) and contrasted to 
upregulated genes in SVF cells after 34 weeks. Go Aspect abbreviations: BP = 





Figure 16: Mitochondrial protein complexes are decreased over time with high fat 
diet treatment. 
A) Western blot of perigonadal adipose tissue (PGWAT) lysates from chow diet (CD) 
and high fat diet (HFD) at 8, 20 and 34 week time points. B) Densitometry analysis 
of protein expression. N=3 mice per treatment group and time point. Data are 
represented as means ±SEM. Two-way ANOVA controlling for false discovery rate 
(FDR<0.05) with Two-stage step-up method of Benjamini, Krieger and Yekutie. 






(Figures 16A and 16B). These same complexes remained significantly decreased after 
20 weeks of HFD (Figures 16A and 16B). Complex III was the only complex measured 
that was significantly decreased between the 8 week CD group and 20 week CD group. 
After 34 weeks, the CD group had reductions in all mitochondrial complexes (1, II, III, 
IV and V) (Figures 16A and 16B). Additionally, the abundance of the complexes in the 
34 week HFD was indistinguishable from the 34 week CD group as both groups had 
similar reductions in protein (Figures 16A and 16B). This was a surprising result given 
the number of mitochondrial genes that were differentially expressed (downregulated) in 
the 34 week HFD compared to the 34 week CD. This highlights the strength of high fat 
stimulus to induce dysfunction in adipose mitochondria. Inflammation has been 
correlated to a decline in mitochondrial complexes and function in adipocytes harvested 
from obese people or treated with conditioned media from cultured macrophages 165. 
High fat diet adipocytes have reduced lipolytic capacity 
  Next given the strong indication from the data to this point that the HFD 
adipocytes are becoming dysfunctional over the 8, 20 and 34 weeks treatment time 
course, I next checked the protein content of enzymes involved in a quintessential role of 
adipocytes, lipolysis, under fasting conditions 166. After 8 weeks of HFD, ATGL protein 
was significantly decreased in total PGWAT lysates that were harvested from the mice 
after a 6 hour fast (Figures 17A and 17B). Total HSL protein was unchanged after 8 
weeks HFD, however phosphorylated HSL on serine 563 (P-HSLser563) which activates 





Figure 17: Lipolysis proteins are dramatically decreased with high fat diet (HFD) as 
well as time in CD. 
A) Western blot of perigonadal adipose tissue (PGWAT) lysates from chow diet (CD) 
and high fat diet (HFD) at 8, 20 and 34 week time points. B) Densitometry analysis 
of protein expression. N=3 mice per treatment group and time point. Data are 
represented as means ±SEM. Two-way ANOVA controlling for false discovery rate 
(FDR<0.05) with Two-stage step-up method of Benjamini, Krieger and Yekutie. 





(Figures 17A and 17B). Total HSL protein showed a trend for decreased at the later time 
points (Figures 17A and 17B). MAGL protein steadily decreased with time irrespective 
of diet, however only HFD after 34 weeks reached significance (Figures 17A and 17B).  
High fat diet leads to increased expression of ECM network, inflammation and ER 
stress markers in isolated adipocytes 
 Given the prevalence of GO term focal adhesion occurring in the top 15 
significantly upregulated GO terms, I extracted the expression data of integrins detected 
in isolated adipocytes during RNA-seq analysis (Figure 18A). Thirty-one genes for 
integrins or related genes were detected. Unsurprisingly, many of the integrins were 
upregulated with HFD. Particularly, integrins belonging to both the alpha subunit (itga3, 
itga4, itga5, itga8, itga9, itga11 and itgax) and beta subunit (itgb2, itgb3, itgb7, and 
itgb8) were strongly upregulated starting at 8 weeks HFD compared to CD control 
(Figure 18A). Numerous collagens, particularly col16a1, as well as fibronectin and 
elastin were upregulated with HFD (Figure 18B). Col16a1 is a fibrillar collagen that acts 
as an adaptor protein that stabilizes the ECM through interaction at focal adhesions 168. 
Col16a1 has been implicated in various tumor models for facilitating an invasive 
phenotype, perhaps through the stiffening of the ECM 169,170.  
GO terms associated with the ER were upregulated in HFD adipocytes. When 
examining the expression of individual genes associated with ER stress, I found that 





Figure 18: High fat diet feeding leads to increased expression of integrins and ECM 
network markers in isolated adipocytes.  
Heat maps were generated using normalized counts from RNA-seq analysis. Log2FC 
was calculated for each group relative to 8 weeks chow diet (CD) group. Genes were 
grouped as follows: A) Integrins B) Collagens, elastin and fibronectin. N=6-8 mice 





Figure 19: High fat diet feeding leads to increased expression of ER stress and 
inflammation markers in isolated adipocytes.  
Heat maps were generated using normalized counts from RNA-seq analysis. Log2FC 
was calculated for each group relative to 8 weeks chow diet (CD) group. Genes were 
grouped as follows: A) ER stress and B) Inflammation and apoptosis markers. N=6-8 






Markers of inflammation (il-6, tnf, il-1b and tgfb1) and apoptosis marker apaf1 were also 
upregulated with HFD in isolated adipocytes (Figure 19B). Interestingly, the 34 week 
CD was also showing increased ER stress and inflammatory markers, again highlighting 
the temporal differences of maturation and high fat stimulus in isolated adipocytes. 
Discussion 
 In conclusion, my data highlight the dynamic transcriptional changes that high fat 
diet elicits in adipocytes. I observed that adipocytes actively respond to high fat stimulus 
through the up and downregulation of thousands of differentially expressed genes. 
Furthermore, my data shows that adipocytes upregulate key components and modulators 
of ECM and fibrosis namely collagen, elastin, fibronectin, integrins and TGF-β1 
signaling thus highlighting an active role for the adipocyte in remodeling of the ECM 
during high fat stimulus. Other groups have previously reported findings with isolated 
SVF cells including single-cell RNA-seq171-173  but to my knowledge this is the first study 
to look specifically at the transcriptional changes in isolated adipocytes during a time 
course of diet-induced remodeling.  
Another key finding was the dramatic downregulation of mitochondrial-
associated genes and pathways as well as the upregulation of markers of ER stress 
starting at 8 weeks HFD and progressing through to 34 weeks. This finding suggested a 
alteration in mitochondrial function that was further supported by decreased OXPHOS 
proteins in total PGWAT. Although with the endpoints measured it cannot be concluded 




mitochondria dysfunction has associated with obesity, insulin resistance and decreased 
adiponectin in mouse adipocytes174,175. The decrease in OXPHOS proteins may also 
suggest a protective mechanism by the adipocyte because of mitochondria being a 
significant source of reactive oxygen species 176. Increased ROS has been shown to 
inhibit adipocyte respiration 177.  
An unexpected finding was the influence of aging-associated weight gain on the 
adipocyte in the 34 week CD adipocytes, as they clustered closer to HFD adipocytes after 
principal component analysis. This further strengthened the data shown in chapter 4 that 
the 34 week CD group as beginning to resembled an earlier HFD group, highlighting the 
different rates of metabolic decline.  
Overall, these data provide a novel, focused view of the transcriptional 
underpinnings of adipocytes in an obese microenvironment over a time course beginning 
at 8 weeks and progressing through to 34 weeks HFD. Adipocytes, no longer an inert 
vessel for storing triglycerides, demonstrate their capacity to dynamically respond to a 
HFD stimulus. A future study evaluating single adipocytes isolated from adipose depots 
through the progression of obesity would allow a deeper dive into the complexities of 
remodeling. Additionally, examining single adipocytes would add the potential to define 
whether the adipocyte population in a remodeling tissue is a homogenous population or if 
adipocytes exist in subpopulations based on more than size and do those populations 
change during the course of remodeling? Defining the heterogeneity of the adipocyte 
population during high fat diet-induced remodeling would provide valuable insight for 




by RNA-seq is still in its infancy given the fragile nature of an adipocyte however given 
the fast advancements in the technology and FACS instruments as well as other tools 
being developed to examine adipocytes such as the NuTRAP mouse178, I believe that this 






CHAPTER SIX –THE ROLE AND REGULATION OF MICAL2 IN 
ADIPOGENESIS AND FIBROGENESIS  
Abstract 
Mical2 is a nuclear protein that was recently shown to be a regulator of 
myocardin-related transcription factor a (MRTFA)-mediated serum response factor (SRF) 
signaling, through its modulation of f-actin, specifically nuclear f-actin 179. Our data 
demonstrate for the first time that mical2 is expressed in both human and mouse adipose 
tissue with enrichment in the visceral stromal vascular fraction (SVF) and expression is 
modulated by high fat diet. We defined the dynamics and impact of mical2 expression 
during adipogenesis. We also demonstrate that mical2 expression is regulated by pro-
fibrotic stimulus, TGF-β1. Pathway analysis to elucidate the mechanism revealed that the 
increase in mical2 expression is not modulated through RhoA-ROCK or MRTFA but 
rather was found to be smad2, smad3, srf and taz expression dependent. Lastly, we 
propose tdg as a potential target gene for mical2. Overall, we uncovered novel biology 
for mical2 in the context of adipogenesis, fibrogenesis as well as a potential link to the 
regulation of smooth muscle gene expression that warrants further investigation. 
Introduction 
The actin cytoskeleton plays a key role in cell movement, polarity and 
differentiation 180. Actin is one of the most abundant proteins in eukaryotic cells and is 
also one of the most dynamic. It is present in 2 forms within the cell: monomers, known 




translational modifications including acetylation, phosphorylation, methylation, 
SUMOylation, ubiquitination and thiol redox modifications 181. During adipogenesis, the 
actin cytoskeleton undergoes extensive remodeling 182. Recently, a conserved family of 
flavoprotein monooxygenases, Molecules Interacting with CasL (MICAL), was 
discovered and characterized for its role in plexin-mediated semaphorin axonal guidance 
required for motor axon pathfinding in Drosophila and mammalian systems 183,184.  
The mammalian family of MICALS consists of three members: MICAL1, 
MICAL2 and MICAL3 184. MICAL2, unlike MICAL1 and MICAL3, is constitutively 
active 185. Detailed enzymatic experiments have revealed that MICAL2 uses redox 
chemistry to dismantle f-actin leading to MICAL2 being classified as an unconventional 
actin binding protein 179,186. Furthermore, MICAL2 is present in the nucleus where it is 
involved in the regulation of myocardin-related transcription factor a (MRTFA)-mediated 
serum response factor (SRF) signaling, through its modulation of f-actin, specifically 
nuclear f-actin 179. The role of MRTFA/SRF signaling was recently shown by the Dr. 
Stephen Farmer and his laboratory to play a key role in adipose tissue and bone 
remodeling through its anti-adipogenic and pro-osteogenic effect on mesenchymal stem 
cells 187,188.  
MRTFA has recently emerged as a major mechanosensor of the extracellular 
environment linking matrix stiffness or cellular tension to gene transcription and cell fate 
determination through its nucleocytoplasmic shuttling 189. TAZ and YAP have also 
gained attention as being mechansosensors. TAZ and YAP are transcriptional cofactors 




well as by the cytoskeleton 88,190. In fact, TAZ expression has been shown to be 
dependent on MRTF expression highlighting the crosstalk of these pathways in the 
context of TGF-β signaling 191. SRF, a cofactor of MRTFA, is also a regulator of smooth 
muscle gene expression and differentiation through its association with myocardin 192. 
MICAL2 has been predominantly studied in the central nervous system 179,184. 
However, recent studies using multiple cancer models have implicated a role for 
MICAL2 in migrating cancer cells and an association with its expression and prognosis 
outcome, demonstrating its role in cell mobility and metastasis 193-196. The role of 
MICAL2 in the context of adipose tissue and fibrogenesis has not been published to our 
knowledge, leaving a very important and novel area to be studied. 
We hypothesized that MICAL2 is an anti-adipogenic protein through its 
regulation of nuclear actin and promotion of MRTFA/SRF-related gene transcription. We 
also hypothesized that MICAL2 is a pro-fibrogenic protein through its regulation of 
nuclear actin and involvement in TGF-β signaling pathways.  
Results 
MICAL2 is enriched in the stromal vascular fraction of human adipose tissue. 
The expression of MICAL2 in human adipose tissue was unknown so I began by 
addressing its mRNA expression in total human subcutaneous (SQ) and visceral (visc) 
adipose tissue as well as adipose tissue that had been fractionated into adipocytes and 
stromal vascular fraction (SVF). I found that MICAL2 is indeed expressed in human 




(Figure 20). MICAL2 expression was also elevated in total visceral adipose tissue and 
visc SVF compared to the SQ total tissue and SQ SVF (Figure 20). 
Mical2 is upregulated with high fat diet feeding in perigonadal adipose tissue 
 Next I asked the question if mical2 expression was modulated under conditions of 
adipose tissue remodeling in the context of high fat diet (HFD) feeding. C57/Bl6J mice 
were fed either chow diet (CD) or 60% HFD for 11 or 34 weeks. At the end of each time 
point, perigonadal adipose tissue was harvested. I found that mical2 expression increased 
with HFD at both 11 and 34 week time points (Figure 21). Interestingly, mical2 
expression was also significantly increased in the 34 week CD group compared to the 11 
week CD group (Figure 21). 
Mical2 is transiently upregulated during adipogenesis 
 Next I used 10T1/2 cells to assess the expression of mical2 during adipogenesis. 
10T1/2 cells were grown to confluence and then induced with adipogenic cocktail to 
stimulate adipogenesis as previously described 187. Mical2 mRNA expression was 
transiently increased after 2 hours of stimulation with adipogenic cocktail (Figure 22). 
By 8 hours, mical2 expression had dropped below its initial expression level at time 0 
(Figure 22). Noteworthy, as mical2 expression declined to below basal levels, this 
coincided with increases in adipogenic genes, particularly pparg and aP2 (Figure 22). 
Overexpression of mical2 suppresses adipogenesis in 10T1/2 cells 
 Given the transient increase in mical2 expression during adipogenesis, I next 





Figure 20: MICAL2 mRNA expression is enriched in the stromal vascular fraction 
of human adipose tissue.  
MICAL2 mRNA expression was measured in total and fractionated human adipose 
tissue from subcutaneous (SQ) and visceral (Visc) depots by qPCR. N= 14-29 donors. 
Means ± sem. 2-way ANOVA controlling for false discovery rate with two-stage step-








Figure 21: Mical2 mRNA expression is upregulated with high fat diet feeding in 
mouse perigonadal adipose tissue.  
C57/Bl6J mice were fed chow diet (CD; orange) or high fat diet (HFD; blue) for 11 or 
34 weeks starting from 6 weeks of age.. N=6-8. Means ± sem. 2-way ANOVA 
controlling for false discovery rate with two-stage step-up method of Benjamini, 






Figure 22: Mical2 mRNA expression is transiently increased during adipogenic 
stimulation of 10T1/2 cells.  
10T1/2 cells were stimulated with adipogenic cocktail and harvested at the 
specified time points for RNA extraction. N=1 experiment with 3 wells of 






question, I overexpressed mical2 in 10T1/2 cells, a mesenchymal cell line, prior to the 
start of differentiation as shown in Figure 23A. After the maturation period, the relative 
efficiency of adipogenesis was compared using bright field images between the empty 
vector or mical2 overexpressing cells (Figure 23B). Adipocytes were estimated based on 
the accumulation of lipid (dark spots). Expression of adipogenic and anti-adipogenic gene 
markers was assessed at the end of the experiment. Compared to empty vector (EV), 
mical2 overexpression led to a dramatic decrease in the expression of adipogenic genes 
pparg, aP2 and plin1 (perilipin) (Figure 23C). Interestingly, anti-adipogenic markers, 
pref-1 and fn1, were elevated 2-fold over EV in the mical2 overexpressing cells (Figure 
23C). Other mical family member mRNA expression was measured to assess effect of 
mical2 overexpression. Curiously, mical1 expression was found to be increased 2-fold 
over EV while mical3 expression was found to decrease 2-fold compared to EV (Figure 
23C). 
Mical2 expression is transcriptionally regulated by TGF-β1 
 Given that I had observed mical2 expression being upregulated with HFD in 
mouse adipose tissue and that it appeared to be anti-adipogenic in mouse mesenchymal 
cells, I next asked the question of whether TGF-β1 could play a role in the regulation of 
mical2. To address this question, I treated serum-starved 10T1/2 with TGF-β1 and then 
harvested cells for RNA extraction and subsequent evaluation of gene expression using 
RNAseq. Using RNAseq for the measurement of mical family gene expression rather  
than qPCR allowed me to directly compare the levels of expression to ascertain which 





Figure 23: Mical2 overexpression suppresses adipogenesis in 10T1/2 cells.  
A) Experimental timeline. 10T1/2 cells were transfected to overexpress Mical2 for 
48 hours prior to start of experiment. B) Bright-field images at day 8. Relative 
degree of differentiation to adipocytes was judged by lipid accumulation that 
appears as dark spots. 4x magnification. C) mRNA expression of adipogenic, anti-
adipogenic and Mical family members. Means ± sem. N=1 experiment with 3 wells of 





 under basal, serum-starved conditions that mical1 had the highest expression followed 
by mical2 and then mical3 (Figure 24). Strikingly, after TGF-β1 treatment, mical2 
 expression was upregulated 7.4-fold over media control (Figure 24). Mical1 expression 
decreased 1.5-fold with TGF-β1 treatment and mical3 expression was unchanged (Figure 
24). 
Mical2 protein expression is upregulated by TGF-β1 
 Building off the 7.4-fold increase in mical2 mRNA expression with TGF-β1 
treatment, I next assessed the protein content as well as localization of mical2. 10T1/2 
cells were treated with TGF-β1 for 24 hours in serum-containing media before being 
harvested for RNA and fractionated for protein measurement and localization analysis. 
After 24 hours of TGF-β1 treatment, mical2 mRNA expression increased 4.3-fold over 
media control (Figure 25A). Next, I measured mical2 protein in 10T1/2 cell fractions 
using western blot. Mical2 protein was detected in membrane as well as soluble nuclear 
fractions under basal conditions (Figure 25B). Mical2 protein was upregulated with 
TGF-β1 treatment and remained predominantly in the membrane and soluble nuclear 
fractions (Figure 25B). Protein amounts for 2 isoforms of actin, γ-actin and β-actin, were 
unchanged with TGF-β1 treatment (Figure 25B).  However, α-SMA protein did appear 
to be upregulated with TGF-β1 treatment (Figure 25B). Curiously, MRTFA protein was 






Figure 24: Mical2 is upregulated with TGF-β1 treatment.  
10T1/2 cells were plated and then serum-starved for 16 hours. After serum-
starvation, the cells were treated with TGF-β1 for 8 hours after which the cells were 
harvested and mRNA was extracted. mRNA expression was measured by RNAseq. 
N=3 independent experiments. Means ± sem. 2-way ANOVA controlling for false 
discovery rate with two-stage step-up method of Benjamini, Krieger and Yekutieli 
(FDR<0.05). **p<0.01, ****p<0.0001.   






Figure 25: Mical2 protein is upregulated with TGF-β1 treatment. 
10T1/2 cells were treated with 1ng/mL TGF-β1 for 24 hours before being harvested 
for RNA and protein extraction. A) Mical2 mRNA expression as measured by qPCR. 
B) Western blot of fractionated 10T1/2 cells after treatment. N=1 experiment with 3 
wells of experimental assay plate for RNA and 1 well of experimental plate for cell 






Transcriptional regulation of mical2 by TGF-β does not involve RhoA or ROCK 
 To begin to elucidate the mechanism behind the regulation of mical2 transcription 
by TGF-β1, pathway inhibition was evaluated using small molecules and siRNA to 
inhibit RhoA-ROCK pathway which was shown to be implicated in mical2 function 179. 
Treatment of 10T1/2 cells with a small molecule inhibitor of ROCK, Y27632, did not 
affect the basal or TGF-β1 stimulated mical2 expression compared to DMSO control 
(Figure 26A). Knockdown of RhoA with siRNA elevated mical2 expression 56% in the 
presence of TGF-β1 treatment (Figure 26B). Knockdown efficiency of RhoA was 89% 
under basal conditions and 93% after TGF-β1 treatment (Figure 26C). 
Canonical TGF-β signaling effectors SMAD2 and SMAD3, SRF and TAZ are involved 
in the transcriptional regulation of mical2 by TGF-β1 
 Next, I evaluated the involvement of other pathways responsive to TGF-β1 
stimulation 197 in the transcriptional regulation of mical2. Knockdown of canonical TGF-
β1 signaling mediators smad2 and smad3 lead to a decrease in TGF-β1-stimulated mical2 
expression (Figure 27A). Intriguingly, knockdown of mkl1 (MRTFA) had no effect on 
mical2 expression however knockdown of srf lead to decreased TGF-β1-stimulated 
mical2 expression (Figure 27A). Similarly, knockdown of taz but not yap lead to 
decreased TGF-β1-stimulated mical2 expression (Figure 27A). The transcriptional 
upregulation of mical2 with TGF-β1 treatment is TGFBRI dependent as when tgfbri was 
knocked down, the effect was lost (Figure 27A). Knockdown efficiencies for the target 






Figure 26: The transcriptional upregulation of Mical2 expression with TGF-β1 
stimulation is not controlled by RhoA or ROCK in 10T1/2 cells. 
A) Serum-starved 10T1/2 cells were pretreated with DMSO, Alk5i (SB431542) or 
ROCKi (Y27632) for 30 minutes prior to stimulation with 1 ng/mL TGF-β1 for 8 
hours. B) Serum-starved 10T1/2 cells that had been reverse transfected with 13nM 
siRNA for RhoA were stimulated with 1 ng/mL TGF-β1 or media for 8 hours. C) 
Knockdown efficiency of siRhoA in serum-starved 10T1/2 cells treated with media 
or 1 ng/mL TGF-β1 for 8 hours. Means ± sem. N=1 experiment with 3 wells of 






Figure 27: Transcriptional upregulation of Mical2 with TGF-β1 stimulation is 
regulated through SMAD2, SMAD3, SRF and TAZ expression. 
A) Serum-starved 10T1/2 cells that had been reverse transfected with the siRNA for 
the indicated target gene and then treated with 1 ng/mL TGF-β1 for 8 hours. B) 
Knockdown efficiency of siRNAs. N=3 independent experiments. Means ± sem. 2-
way ANOVA controlling for false discovery rate with two-stage step-up method of 
Benjamini, Krieger and Yekutieli (FDR<0.05). Significance relative to Scrambled 
control**p<0.01, ****p<0.0001. Significance relative to Scrambled + TGF-β1; 





Table 14: Calculated % knockdown efficiency of 10T pathway analysis in Figure 
24B. 
Knockdown efficiency was calculated from the data in Figure 24B as % knockdown 






Tdg expression is downregulated with mical2 knockdown 
 To evaluate the importance of mical2 in 10T1/2 mesenchymal cell transcriptional 
signature, I treated 10T1/2 cells with either scrambled control or siRNA for mical2 and 
prior to treatment with 1 ng/mL TGF-β1 for 8 hours. The cells were then harvested and 
prepared for RNAseq analysis. Mical2 expression was regulated by TGF-β1 treatment as 
seen in previous experiments and expression was efficiently knocked down with siRNA 
treatment (Figure 28A). Under basal conditions, mical2 knockdown lead to the 
upregulation of 163 differentially expressed genes when comparing siMical2 to 
siScrambled samples and selecting genes with padj<0.05. The top 20 genes are listed in 
Figure 28B. Mical2 knockdown led to the downregulation of 168 differentially expressed 
genes when comparing siMical2 to siScrambled samples and selecting genes with 
padj<0.05. The top 20 genes are listed in Figure 28C. Mical2 was at the top of the 
downregulated gene list along with tdg and its pseudogene gm9855 (Figure 28C). 
Tdg mRNA expression is regulated by TGF-β1 and follows mical2 expression 
 To investigate tdg further, I extracted the normalized counts expression data from 
the RNAseq experiment. Intriguingly, tdg expression was upregulated with TGF-β1 
treatment (Figure 29). Furthermore, both basal and TGF-β1-stimulated tdg expression is 
decreased with mical2 knockdown (Figure 29). Thus suggesting that tdg may be a target 
gene of mical2. 
Discussion 
 The aim of this body of work was to gain insight into mical2 in the context of 






Figure 28: Knockdown of Mical2 is 10T1/2 cells results in loss of Tdg expression. 
10T1/2 cells that had been reverse transfected with siMical2 construct were serum-
starved before stimulation with 1 ng/mL TGF-β1 for 8 hours. Cells were harvested 
and processed for RNAseq analysis. A) Mical2 mRNA expression. B) Top 20 
upregulated genes in 10T1/2 cells after knockdown of Mical2 (basal conditions). C) 
Top 20 downregulated genes in 10T1/2 cells after knockdown of Mical2 (basal 






Figure 29: Both basal and TGF-β1 stimulated Tdg mRNA expression are altered 
with knockdown of Mical2 expression. 
10T1/2 cells that had been reverse transfected with siMical2 construct were serum-
starved before stimulation with 1 ng/mL TGF-β1 for 8 hours. Cells were harvested 
and processed for RNAseq analysis. Means ± sem. Data represent N=3 independent 
experiments. 2-way ANOVA controlling for false discovery rate with two-stage step-





 area. The bulk of mical2 research has occurred in neural cells where it was first found to 
play a role in in axon guidance and plexin-semaphorin signaling through its regulation of 
actin 184,198. This has changed in recent years as mical2 has garnered attention in the 
cancer field as it emerged to play a role in cell migration, tumor metastases and increased 
expression associated with a poorer prognosis 193-196,199. 
Here, I have uncovered novel biology showing not only that mical2 is expressed 
in both human and mouse adipose tissue but that expression is enriched in the SVF 
compared to adipocytes. I also found that mical2 is transiently upregulated during 
adipogenesis and that sustained expression results in the suppression of adipogenesis and 
maintenance of 10T1/2 cells in a precursor state. Excitingly, I uncovered that mical2 is 
transcriptionally regulated by TGF-β1. When I started to investigate the potential 
mechanism behind this regulation, I found that not only was MRTFA not involved in this 
regulation but neither was RhoA and ROCK. This result was surprising given recently 
published work demonstrating that mical2 as being involved in the regulation of 
MRTFA/SRF 179 as well as mical2 being shown to be a target gene in serum-stimulated 
fibroblasts103. A curious observation was that MRTFA was predominantly located in the 
cytoplasm, although not absent from the nucleus during TGF-β1 stimulation especially 
since α-SMA, a target gene of MRTFA/SRF, appeared to be upregulated with TGF-β1 
treatment. Also, the majority of mical2 was located in the nucleus. Intriguingly, I found 
that srf was involved in the TGF-β1-mediated transcriptional regulation of mical2 





Lastly, I uncovered a novel finding of tdg being transcriptionally regulated by 
TGF-β1 as well as its expression being effected by the suppression of mical2 in 10T1/2 
mesenchymal cells. Tdg has been shown to be a regulator of SRF/myocardin interactions 
and expression of smooth muscle genes 200. Srf is a transcriptional cofactor for the 
regulation of many different gene programs particularly the myocardin family in regards 
to muscle differentiation, contraction, cell migration and growth notably in smooth 
muscle cells 192,201. Vascular smooth muscle cells reside within the vasculature of the 
adipose tissue closely associating with pericytes and have been referred to collectively as 
mural cells 202. These cells have been shown to have the ability to differentiate to 
adipocytes as well as myofibroblasts depending on the stimulus and differentiation state 
203-206. This is especially intriguing given my data demonstrating that mical2 is regulated 
by TGF-β1 treatment and furthermore that knockdown of srf but not mkl1 blunts the 
upregulation of expression. 
These data suggest a potential role of mical2 in smooth muscle cells and possibly 
mural cells in response to pro-fibrotic stimulus, TGF-β1 in a feedback loop for the 
expression of smooth muscle genes. A working model for the proposed regulation of 






Figure 30: Working model of Mical2 and Tdg. 





CHAPTER SEVEN – FINAL CONCLUSIONS AND FUTURE DIRECTIONS 
Summary of key findings 
 In summary, there are two bodies of work that make up this thesis. The first body 
of work provides a novel view and first step into understanding the processes and 
pathways occurring within an adipocyte during the progression of obesity. The second 
body of work centers around MICAL2, an atypical actin regulating protein, whose 
presence or potential role in the adipose tissue was previously unknown.  
 The data within the first body of work demonstrate that chronic high fat diet 
(HFD) feeding lead to a progressive decline in the metabolic health of the mice as obesity 
developed. This was evident by elevated fasting insulin (Figure 3) as well as ectopic 
lipid accumulation in the liver (Figure 5). These results and other metabolic endpoints 
collected are in agreement with published studies of HFD-induced obesity 80,104. 
A interesting observation from this study was the onset of age-related obesity in 
the chow diet (CD) group by 34 weeks. For many endpoints, the 34 week CD mice 
resembled an earlier HFD phenotype thus suggesting accelerated aging with high fat 
feeding and that when given enough time, the CD group will resemble a HFD group in 
terms of metabolic dysfunction. High fat diet has been shown to accelerate aging in the 
brain as evidenced by neurological decline associated with increased inflammation and 
oxidative stress 207-209. Obesity is also becoming recognized as a disease of the elderly 139. 
Principal component analysis of transcriptomic data of isolated adipocytes from the CD 
and HFD groups added further strength to the observation that the 34 week CD resembled 




near each other with the exception of the 34 week CD group. The 34 week CD group not 
only clustered away from the earlier CD time points but was separated from the other CD 
groups by the 8 week HFD group further suggesting that these groups shared similarities.  
Another intriguing observation came after evaluating the stromal vascular fraction 
(SVF) and adipocyte fractions across the time course for both diets by qPCR. It became 
clear that at least for the remodeling and inflammatory genes evaluated that the SVF 
responded to time rather than high fat (Figures 7 and 8). This was sharply contrasted by 
the isolated adipocytes which responded to high fat stimulus more strongly than time. 
Overall, demonstrating a fascinating differential response of the two cell compartments 
residing within the same microenvironment and presumably exposed to the same pool of 
stimuli.  
When considering the RNA-seq data for looking directly at the transcriptional 
signature in an isolated adipocyte, for the pathway analysis I took a reductionist approach 
using the SVF rather than simply looking at the isolated adipocyte fraction on its own 
(Figure 13). I did this to address the potential for sticky cells from the SVF to have been 
carried over into the isolated adipocyte fraction. A concern for this was raised by Ebke 
and colleagues as they found lipid-rich macrophages in the adipocyte fraction when they 
used a similar collagenase digestion paired with density centrifugation method to 
fractionate the adipose tissue 210. By removing the genes that were differentially 
expressed in both SVF and adipocyte fraction (in common) as well as those specific to 
the SVF, I believe this allowed me to minimize the potential for SVF cells to affect the 




potential for SVF cells being present in the adipocyte fraction was most likely minimal 
was when I measured remodeling and pro-fibrotic gene expression by qPCR in the same 
samples that were used for the RNA-seq experiment (Figure 9). When comparing the CD 
SVF to the CD adipocytes, the SVF cells are upregulating remodeling genes beginning at 
8 weeks and continuing through to 34 weeks. In contrast the CD adipocytes only 
upregulated a handful of the genes and not to the extent as the SVF. Altogether, this gave 
me confidence that the pathways and genes that I report here are specific to the adipocyte. 
A potential method to circumvent this concern would be use a transgenic mouse 
expressing a fluorescent protein marker driven by a collagen promoter specifically in 
adipocytes. This would allow for the analysis of what cells are expressing the collagen of 
interest, such as col1a1.   
Transcriptomic analysis of SVF and isolated adipocytes over the time course 
revealed the largest number of differentially expressed genes in both fractions when 
comparing HFD to CD at the 20 week time point (Figure 9). This highlights 20 weeks of 
HFD as a time of dynamic change in both cell fractions as well as perhaps a time of 
heightened remodeling. Additionally, increased elastin staining of the PGWAT in the CD 
group was also found at the 20 week time point further highlighting it as a time of active 
remodeling in response to both high fat and time. Strissel and colleagues demonstrated a 
similar peak at 16 weeks of remodeling through the measurement of different parameters 
in their time course analysis of adipose tissue remodeling with high fat diet fed mice 80.  
When investigating the broad transcriptional changes occurring within the 




and pathways at all time points evaluated. After 8 weeks of HFD, the adipocyte appeared 
to ramping up pathways and genes associated with protein processing, namely the ER, 
Golgi and proteasome. By 20 weeks, signs of ER stress were beginning to arise with the 
unfolded protein response pathway, more focal adhesion genes and ECM organization 
pathway coming into play. After 34 weeks, it appears that the adipocytes were familiar 
and attempting to cope with the pro-inflammatory and fibrotic microenvironment 
supported by the SVF. Genes associated with the cytoskeleton and focal adhesion 
pathways continued to increase in number from earlier time points suggesting that the 
adipocyte was responding to an ever increasingly tense environment. Notably, MRTFA 
target genes and genes related to TGF-β signaling such as col1a1, fn1, ctgf, itga5 and 
tgfb1 were upregulated. Dr. Stephen R. Farmer and his  laboratory recently elucidated the 
role of MRTFA in driving precursor cells to a pro-fibrotic state during obesity 104. 
Perhaps my data are suggesting that MRTFA may be a leading cause of the adipocyte 
acquiring a more fibroblast-like phenotype.  
Overall, these data paint a picture of adaptation from the adipocyte through the 
upregulation of ECM-related genes and pathways in an effort to remodel its environment. 
However this was coupled with a decline in the metabolic health of the adipocyte 
suggesting an inability to cope with the chronic stress of a high fat environment. 
Intriguingly, these data could also suggest that the adipocyte is beginning to express 
markers and turn on pathways that it once did as a preadipocyte as outlined in Figure 31. 
As a preadipocyte, the cell maintained its fibroblast morphology in part through the 





Figure 31: Working model of adipocyte in obesogenic microenvironment. 
Our working model of the effect of high fat diet on the expression of various makers 





precursor state. After the cell receives an adipogenic stimulus, the cell undergoes a major 
shape change which requires remodeling of the microenvironment in order to 
accommodate the new, round adipocyte. The adipocyte expresses on genes and turns on 
pathways associated with maintaining its function such as PPAR-γ and lipogenesis 211,212. 
Under a high fat diet stimulus, the adipocyte presumably begins to undergo another shape 
change as it experiences the tension from the surrounding ECM 67. My data suggest that 
the adipocyte is now beginning to express anti-adipogenic and pro-fibrotic pathways 
genes and pathways that it once did as a precursor cell. Altogether suggesting that the 
adipocyte is reverting to an earlier time in its lifecycle in its attempt to cope with high fat 
environment. The possible crosstalk of these anti-adipogenic and pro-remodeling 
pathways104,187,197,213 is presented in Figure 32.  
 These data are certainly exciting and it should be noted that there are differing 
views in the adipose remodeling field as to what cells within the adipose tissue are 
contributing to ECM deposition and turnover.  Dr. Phillip Scherer and his laboratory 
published an excellent review where it was made clear that they believe adipocytes and 
cells within the SVF participate in ECM remodeling 214. A recent paper published by 
Karine Clement and her laboratory make a compelling argument that PDGFR-α(+) and 
CD9(high) cells within the SVF are the significant contributors to ECM 215. The data that 
I present in this thesis demonstrate that the adipocytes are playing a role in ECM 
remodeling of their environment but I do not believe that adipocytes are the dominant 
contributors to ECM in the adipose tissue. It is important to note that the genes and 




high fat stimulus compared to chow diet and were not found in the SVF at each of the 
time points. Furthermore, based on my qPCR data, it appeared that the SVF cells did not 
respond strongly to high fat stimulus.  
 In the second body of work, I focused on evaluating a protein called Mical2. 
Mical2 caught Dr. Stephen R. Farmer and his  laboratory’s interest because of a recent 
publication from Lundquist and colleagues where they demonstrated that mical2 played a 
role in regulating MRTFA/SRF signaling though its regulation of nuclear actin 179. The 
bulk of mical2 research has been done primarily in the context of the central nervous 
system, where it has high expression and was first found to play a role in plexin-
semaphorin signaling and axon guidance through its regulation of actin 184,198 leaving its 
status in adipose tissue as a new area of research. I demonstrated that MICAL2 was 
indeed expressed in human and mouse adipose tissue and furthermore that it was 
enriched in the SVF compartment of perigonadal adipose depot and upregulated by 












 intriguingly that it wasn’t dependent on MRTFA but instead on SRF. A potential target 
gene, tdg, was identified which strengthened the connection to SRF as well as to smooth 
muscle cells and possibly mural cells within the adipose tissue. Mural cells, which reside 
close to the vasculature and smooth muscle cells, have been shown to have the ability to 
differentiate to adipocytes and have been suggested to be a precursor of adipocytes 
including beige adipocytes in vivo 216.  
Additionally, recent studies in the cancer field have been published highlighting 
mical2 as playing a role in cell migration, mesenchymal to epithelial transition, tumor 
metastases and with increased expression associated with a poorer prognosis 193-196,199. 
This is especially intriguing for 2 reasons. One, TGF-b1 signaling has been well studied 
in the cancer field thus suggesting a mechanism for mical2’s regulation in tumors217. And 
two, given the novel data that I have presented here in terms of thinking of a potential 
role for mical2 in myofibroblasts, given its regulation by TGF-β1 and anti-adipogenic 
function, and adipose tissue fibrosis. Thus highlighting potential roles for mical2 in 
adipose tissue that warrants further investigation. 
Future directions 
To take the observations from my HFD mouse studies a step further, I would 
propose a future study evaluating single adipocytes isolated from adipose depots through 
the progression of obesity. This would allow a deeper dive into the complexities of HFD-
induced remodeling. Given the data presented here, I would propose looking at earlier 
time points of HFD before metabolic dysfunction sets in and before the perigonadal depot 




to define whether the adipocyte population in a remodeling tissue is a homogenous 
population or if adipocytes exist in subpopulations and how those populations change 
during the course of remodeling? Also how do the population(s) of adipocytes relate to 
the different populations of cells within the stromal vascular fraction? A recent study 
using single cell RNAseq identified a subpopulation of cells within the SVF that the 
authors concluded was inhibiting adipogenesis 218. Defining the heterogeneity of the 
adipocyte population during high fat diet-induced remodeling would provide valuable 
insight and the potential for identifying new targets for the treatment of obesity-related 
diseases. The ability for evaluating single adipocytes by RNA-seq is technically very 
difficult given the fragile nature of an adipocyte. However, given the recent 
advancements in tools being developed to examine adipocytes such as the NuTRAP 
mouse178 as well as advances with cell sorting instruments, I believe that this will be 
possible in the not too distant future. 
The observation of the effect of aging on the SVF was intriguing. As a follow-up 
study it would be interesting to age mice in a weight-neutral state of energy balance to 
limit the expansion of the adipose tissue. This would allow for the detailed analysis of 
whether it is the obesity-mediated expansion or age of the tissue that drives the pro-
fibrotic state of the SVF and associated response from the adipocyte.  
To evaluate the importance of the different pathways involved in adipocyte-driven 
remodeling as suggested by my data and depicted in Figure 32, acquiring or generating 
floxed mice for the different pathways (MRTFA, SMAD2/3 and TAZ/YAP). These mice 




these pathways in the context of the adipocyte in relation to high fat-stimulated 
remodeling.  
For Mical2, based on the exciting data presented here, I would propose digging 
deeper into its role in adipose tissue remodeling in both the context of fibrosis as well as 
browning. This could be done by generating a floxed Mical2 mouse that could then be 
crossed with various inducible cre mice for mural cell or adipocyte markers for example 
to knock mical2 out these cells allowing the analysis and characterization of mical2 
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